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ABSTRACT:
FLASH ultra-high dose rate radiotherapy (RT) is one of the most rapidly growing
subfields of radiation oncology today due to its potential to increase the limits of the
therapeutic ratio. The FLASH effect, which includes heightened normal tissue sparing
paired with iso-effective tumor cell killing, has been literature documented, in a limited
manner, in rodent models, a few large animals, and one clinical patients.
A porcine-based experiment was conducted to test the effects of FLASH RT on
normal tissue compared to conventional (CONV) RT. A clinical linear accelerator
(LINAC) was reversibly converted to be capable of FLASH RT. A female Yucatan minipig was irradiated at both CONV and FLASH dose rates at four different dose levels: 0,
20, 30, and 40 Gy. Gafchromic film was used for dosimetry. To assess for radiationinduced skin reactions, two novel apps were developed in MATLAB App Designer in
order to quantify previously unquantifiable data. These data included skin pigmentation
metrics from RGB iPhone images as well as epithelial melanin concentration from
Masson-Fontana histological stain images. To assess RT-inducted skin damage, both an
H&E histological stain and Optical Coherence Tomography (OCT) were implemented for
measuring epithelial thickness.
Two trends were consistent across our data. First, skin reaction in terms of
pigmentation, epithelial melanin, and epithelial thickness all varied proportionally with
radiation dose within FLASH and CONV RT modes. Second, FLASH elicited a stronger
RT-induced response across all three metrics. However, the epithelial thinning damage,
based on H&E histology, was not statistically significant.
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From a regression analysis, our data suggests skin pigmentation can be linearly
modelled to predict epithelial thinning as a result of FLASH and CONV RT and may
serve as an important noninvasive alternative for assessing radiation-induced skin
damage. The FLASH effect normal tissue sparing theory was not demonstrated by this
short term single animal study however it provides excellent evidence for use in future,
more comprehensive FLASH radiation studies. More research should be conducted in
order to bolster the strength of the currently crude linear model which correlates skin
pigmentation with RT-induced epithelial thinning.
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INTRODUCTION:

Overview of Thesis
“In 2018, [Lausanne University Hospital] showed complete disappearance of a
tumor in a resistant superficial skin cancer, with nearly no side effects. This first for
FLASH treatment on humans accelerated the clinical translation of FLASH therapy” [1].
The aforementioned discovery prompted CERN, the world’s largest particle physics
laboratory in the world, to develop a new facility dedicated to enabling FLASH research.
Since its rediscovery in 2014, and its revitalization by the aforementioned clinical
experiment and publication in 2018, FLASH radiotherapy (RT) has experienced an
exponential increase in investment over the past few years of scientific research. The
nickname FLASH comes from the characteristics of this novel form of radiation therapy.
Administered at a dose rate sometimes 3000 times than conventional radiotherapy (300
Gy/s vs. 0.1 Gy/s), FLASH RT allows for a normally 20 second treatment to be cut to just
6 milliseconds [2]. Moreover, recent evidence has shown that FLASH RT might be
equally as effective as CONV RT in terms of tumor growth repression [3] while
exhibiting increased normal tissue sparing [4]. FLASH RT has sparked widespread
excitement through the community of radiation oncology. FLASH RT has attracted
millions of dollars in biomedical research investments. This novel technology has serious
potential to save lives and improve radiotherapy across the medical world. “I’ve never
seen this much investment and excitement over a breakthrough in biology with this little
data”. The aforementioned statement documents an honest observation on FLASH ultrahigh dose rate radiotherapy from Dr. P Jack Hoopes, Professor of Surgery and Radiation
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Oncology at Geisel School of Medicine and Director of the Center for Comparative
Medicine and Research at Dartmouth-Hitchcock Medical Center. Dr. Hoopes, the advisor
of this project, is a known advocate for FLASH RT funding and research. Still, both
aspects of Dr. Hoopes’ point are simple and well received: FLASH RT is an exciting
development and we need more data to prove its worth.
Overall, the goals of this project were simple. Firstly, we aimed to investigate,
and potentially corroborate recent literature on, the effects of FLASH vs conventional
(CONV) RT on healthy animal tissue via the golden standard of histology. Secondly, and
more uniquely, we worked to explore two alternative, non-invasive methods for
investigating FLASH RT-induced damage which might be able to serve as potential
substitutes for invasive biopsy. The first method involved changes in skin pigmentation: a
non-invasive but non-functional alternative. The second is Optical Coherence
Tomography (OCT): a non-invasive and functional alternative. Additionally, we explored
RT-induced changes in epithelial melanin via a Masson-Fontana histological stain as well
as a standard Hematoxylin and Eosin (H&E) histological stain to quantify epithelial
thinning. Ultimately, multiple conclusions were met at the end of this project. Firstly,
FLASH RT correlated with increased skin pigmentation. Secondly, FLASH RT
correlated with decreased epithelial thickness. And thirdly, changes in RT-induced skin
pigmentation can be linearly modeled to predict epithelial thinning and used as a noninvasive indicator of RT-induced damage.
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Introduction to the Field of Radiotherapy

History of Radiation Therapy: Invention through the Present
Through the initiative of the German physicist Wilhelm Rontgen, the discovery of
x-ray technology exploded across the scientific community in 1895. It took only one year
for researchers to posit that the x-ray might be explored as a curative medical technique.
In turn, on January 29th, 1896, Dr. Emil Herman Grubbe became the first person to apply
x-ray radiation to pathologic lesions on a living cancer patient in a Chicago factory. Mrs.
Rose Lee, this historic first patient, presented with an open and inoperable carcinoma on
her left breast associated with inevitable and early death. Dr. Grubbe used two Crookes
tubes for irradiation paired with protective sheet lead, taken for a Chinese tea chest, to
guard the surrounding healthy tissue [5]. This initial treatment was never proven effective
as Mrs. Rose Lee passed from systemic carcinosis less than a month after her first
treatment [5]. Regardless, the experiment catalyzed the field of exploratory biomedical
radiation to come. The ambition of these scientists and others, including Maria
Sklodowska-Curie and Pierre Curie's discovery of radium as the source of radiation,
catalyzed the exponential growth of one of the most influential oncologic fields of
medicine. At the most fundamental level, radiotherapy is the medically targeted use of
high energy rays or radioactive materials in order to damage, stunt, or kill tumor cells [6].
While radiotherapy is not confined to the therapeutic treatment of cancer, the scope of
this thesis will be limited to it. In the last 120 years, great strides have been made in
cancer radiotherapy. Fractionation and precise volume optimization now serve to widen
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the gap between tumor damage and normal tissue sparing [7]. The Mayo Clinic reports
that radiation therapy is needed in more than half of all cases [8]. Further, some sources
say that two-thirds of cancer patients receive radiotherapy as at least part of their
therapeutic treatment experience [6]. In fact, after surgery, radiotherapy is typically
considered the most important cancer treatment. This tenet rings especially true for
localized tumors that have not metastasized [9].

How does Radiotherapy Work?
Ionizing radiation typically induces two types of cell death: necrosis and
apoptosis [9]. Necrosis is generally characterized as passive cell death where DNA
aberrations are not repaired before mitotic divisions and, thus, daughter cells incur lethal
repercussions. Conversely, apoptosis is an active initiation of programmed cell death in
response to cellular stress [9]. Death types aside, a myriad of studies over the course of
several decades all point to the fact that DNA is the critical target of RT. It is well known
that irradiation prompts both DNA single strand breaks and lethal DNA double strand
breaks [9]. Warters and Hofer’s 1977 study, which set out to elucidate the primary site of
radiation damage, found that radiation-induced mitotic delay is caused by damage
specific to the nucleus [10]. Postulating that a low energy emitter, 125I, attached to the
plasma membrane would yield different mitotic delays based on which part of the cell
was critical to radiation-induced cell death, it was found that nearly 20,000 decays/cell at
the cell membrane was required to yield a 3-hour delay whereas only 60 decays/cell at
the nucleus led to equivalent cell survival. This metric indicated that the nucleus, and thus
the DNA, is the critical target for radiation-induced cell death [10]. Studies investigating
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the effects of radiation on immunodeficient mice have further corroborated evidence
suggesting that nuclear damage and DNA repair kinetics are primarily responsible for the
medical side effects of radiation. Severe Combined Immunodeficient (SCID) mice, for
example, are deficient in a recombination process essential to DNA double-strand break
repair and, consequently, present with cellular hypersensitivity to ionizing radiation [11].

Radiosensitivity and Radioresistance
One of the core tenets of radiotherapy lies in observing and exploiting the fact that
normal tissue can recover from harmful ionizing radiation more effectively than tumor
tissue [12]. Admittedly, the aforementioned principle is an oversimplified blanket
statement. Even tumors from the same histological group and developmental stage have
been found to vary widely in terms of radioresistance [13]. Not surprisingly, tumor
radiosensitivity and resistance are influenced by a plethora of factors. Tumor
radiosensitivity is affected by oxygen consumption, DNA repair mechanisms, the number
of clonogenically capable cells, the number of cells dividing, and the distribution of cells
throughout the various phases of the cell cycle [13]. Pawlick et al. report that potentially
the most critical factor dictating cellular radioresistance is genetic, where certain gene
expressions may result in particularly radioresistant tumor strains [9]. For example, the
wild-type p53 gene has been identified to sensitize tumor cells to ionizing radiation,
while p53 mutations have a variable impact on tumor response to treatment [13].
Evidence for genetic influence of tissue response to ionizing radiation comes from the
observation that patients with the same histological diagnoses - in other words, patients
with the same cancers in the same places - show significant variation in response to
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radiotherapy. Even more telling, variation in radiosensitivity has also been found to exist
within a single tumor [9]. Beyond genetics, specific cancers differ in their intrinsic
sensitivity to radiation. Some cancers are very responsive to low doses of radiation;
examples include lymphomas (cancers of the lymph system) and seminomas (cancers of
the testicle) [9]. On the contrary, some tumor strains are particularly radioresistant and
are not quelled even after high irradiative doses [9]. Melanomas and glioblastomas found
in the brain exhibit this highly radioresistant behavior. Physical tumor factors also play a
role in the success of radiotherapy against tumor cells. Characteristics can include but are
not limited to tumor size, location, vasculature, and, in turn, access to oxygen [9].

Role of the Cell Cycle in Radiotherapy and Radiosensitivity
To fully understand how radiation acts as a cancer therapeutic, it is vital to
consider the cell cycle and mitotic division. Cell cycle division might be aptly described
as a series of coordinated events that result in the replication of DNA and the division of
a cell [14]. In order for a cell to split into two daughter cells through a process
called mitosis, it must meander through all 5 phases of the cell cycle [15]. In any given
cycle, chromosomes are replicated and segregated in two separate phases. These DNAfocused phases are split by stages of rest, growth, and reorganization [14]. Regulating cell
division progress, broadly speaking, are two distinct mechanisms: a kinase cascade of
protein phosphorylations that signal cells to transition forward and various checkpoints
which monitor and delay cell cycle progression if necessary [14]. The first stage of cell
life is the G0 phase. In G0, a cell is at rest and performs its genetically encoded functions.
Cells spend much of their life in this stage. Movement from G0 to G1 marks a period of
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preparation for division. In G1, protein production is enhanced, and RNA intended for
DNA replication is produced [15]. In the next phase, the S phase, the chromosomes are
duplicated. G2 phase marks a waiting period immediately before division. Lastly, the
cells split into two identical daughter cells in Mitosis (M Phase) [15].
On the surface, the connection between cancer and the cell cycle is self-evident;
the cell cycle controls cell proliferation, and cancer is a disease of uncontrolled cell
division [14]. The relationship between the cell cycle, cancerous tumors, and radiation
therapy is somewhat more complicated. The cell cycle phase is an essential factor for
radiotherapeutic efficacy; the various cell cycle phases uniquely influence
radiosensitivity [15]. In fact, cell cycle regulation is arguably the most critical factor
influencing ionizing radiation sensitivity in both tumorous and normal cell lines. Cell
cycle phases are differentially radiosensitive. Cells are the most sensitive to radiotherapy
through the G2-M phases because these stages do not involve nearly as significant
concentrations of activated DNA repair machinery [9]. The G1 phase, which is a period
of preparation before chromosome replication, is somewhat less radiosensitive. Least
sensitive are cells in the S phase, which are in the midst of chromosome duplication and
present with the most active DNA repair machinery [9]. This trend in cell cycle phase
radiosensitivity follows the logic that the more a cell focuses on DNA duplication and
replication, the more radioresistant it will be. Conversely, cells allocating more energy
towards rest, generalized growth, and division are inclined to be more radiosensitive.
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Influence of Gene Expression on Radiosensitivity
Another major biological factor that influences therapeutic radiosensitivity is gene
expression. The rapidly growing field of radiogenomics typically investigates how
genetic variation might affect the levels of radiotoxicity experiences across genetically
unique individuals with the ultimate goal of tailoring therapeutic radiation therapy to the
patient based on their genetic composition [16]. The clinical impact of this field is
apparent when considering the limitations of current radiotherapy administration.
Generally, a radiotherapy treatment regimen is required to follow this rule of thumb: the
risk of severe side-effects such as surrounding healthy tissue toxicity must not exceed 510% [17]. While critical to ensure the safety of every patient, this 5-10% metric is largely
skewed by the particularly radiosensitive outlier patients. This skew suggests that a
majority of patients could tolerate a much larger and more effective dose. In fact, it is
estimated that 80% of the variation in radiotherapy-induced toxicity can be attributed to
unique patient variation (i.e., genetics) [16]. Scaife et al. suggest that considering late
skin toxicity as a metric in question, that the most resistant 40% of RT patients ought to
be receiving a 20% higher dose for optimal therapeutic efficacy [18]. Thus, genetics play
an enormous role in the overall effectiveness of radiotherapy as a weapon in the medical
arsenal of cancer treatments and must be taken into consideration in pre-clinical
radiotherapy research.
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Introduction to FLASH Ultra High Dose Rate Radiotherapy

Discovery and Rediscovery of FLASH RT
The revitalization of FLASH radiotherapy erupted in 2019 through the initiative
of a Swiss research team at the University of Lausanne. Lesser known is FLASH’s initial
discovery, which dates back to 1966 [19]. During the 1960s, laboratory scientists
interested in the fundamental underpinnings of radiobiology were investigating the
biological effect of irradiation on mouse models. One fundamental question of interest at
the time was, “how much radiation does it take to kill mice”? In scientific literature, this
metric of radiative potency, or killing efficiency, is written as L.D. 50/30 and stands for
the mean dose required to kill 50% of a mouse population in 30 days. Unexpectedly,
Hornsey et al. discovered that the mean dose rate required to kill mice within four days
(L.D. 50/4) was strongly dependent on dose rates up to 6000 rad/min [19]. In other
words, ultra-high dose rate radiation was significantly more effective at administering
tissue damage and, ultimately, killing mice.
Further, in 1974, Field et al. discovered a peculiar sparing of rat skin in response to
changes in radiation dose rate. As the dose-rate increased to 500krads/min on the feet of
anesthetized rats, the damage efficacy of the radiation diminished [20]. The mechanism
of FLASH was not known in 1974 and is still essentially unknown today. Thus, Field and
Bewley’s speculations on the FLASH effect’s integration with oxygen mechanics cannot
be verified. Still, their radiation research in the mid-70s on rat skin marks one of the first
mentions of the FLASH effect. For nearly 40 years afterward, the FLASH effect and the
popularity of experimenting with ultra high dose-rate radiotherapy was largely forgotten.
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It wasn’t until 2014 at the University of Lausanne that FLASH RT made its scientific
resurgence. Prompted by in vitro studies suggesting that sub-millisecond pulses of
radiation might induce less genomic instability than conventional protracted radiation, a
French research team set out to investigate the potential of ultra high dose-rate
radiotherapy through a lung fibrogenesis study in a nude mouse model [3]. One cohort of
mice was irradiated with short pulse FLASH RT where administration clocked in at ≤
500ms pulse intervals and ≥40 Gy/s dose-rates. Another cohort of nude mice incurred
conventional dose-rate irradiation at ≤0.03 Gy/s in single-dose form. Using both a human
tumor xenograft and syngeneic orthotopic lung tumor model, the researchers found that
conventional (15 Gy) radiotherapy triggered lung fibrosis where FLASH radiotherapy
under 20 Gy induced no complications for more than 36 weeks after irradiation [3]. More
impressive: FLASH RT was iso-effective with CONV RT in terms of tumor growth
repression. This lung fibrosis model marked a modern rediscovery of the potential of
FLASH RT techniques. This study inspired the Swiss team at the University of Lausanne
Hospital to experiment with FLASH in a clinical environment for the first time. This
meeting of FLASH RT and human subject returned promising results and will be further
discussed in this thesis. Most importantly, these two instances in the history of FLASH
radiotherapy have, in large part, contributed to its massive resurgence in the field of
radiation oncology.

What is FLASH RT?
Over many years of clinical radiotherapy research, two major optimizations have
come into play in a continuous attempt to minimize collateral healthy tissue damage. The
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first RT factor affecting normal tissue tolerance is the fractionation of the total dose in a
series of treatments. [3,4]. This method of medical optimization through dose
fractionation dictates the stereotypically drawn-out processes which define modern
radiotherapy treatment regimes. The second factor is dose-delivery precision. In other
words, how accurate the irradiative machinery is at hitting its cancerous target while
missing the surrounding innocent tissue. [4]. Admittedly, there are other focus areas of
development and optimization in radiotherapy aside from fractionation and delivery
precision. These include advances in chemoradiation, improved imaging techniques,
accelerator and computer technologies developments, and more [3]. FLASH ultra-high
dose rate radiotherapy finds relevance in being its own novel therapeutic optimization
factor: it is evidenced to better spare normal tissue while significantly shortening the
overall time for total dose delivery. This discovery is especially compelling when
considering its implications on the treatment of radioresistant tumors, given that their
treatment is currently most restricted by dose-limiting normal tissue complications [40 Zhou - p. 35]. Conventional clinical tumor irradiation typically comprises a dose rate of ≤
0.03 Gy/s [4]. Conversely, FLASH RT is generally delivered at >40 Gy/s for total
treatment durations at or below 500ms [3]. Granted, the full definition of what defines an
irradiative treatment as “FLASH” is significantly more complex than dose rate and total
duration. It also includes several additional parameters, including pulse width, pulse
number, repetition rate, and total duration exposure [4]. That said, dose rate and duration
time are currently the most well-defined parameters for FLASH in the literature, as
previously referenced. The latter parameters are much less well defined in preclinical
literature. Current evidence suggests that FLASH offers a number of benefits over CONV
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RT. However, two overarching principles primarily differentiate FLASH. Firstly, across
many sequential treatments, CONV RT is often administered in aggregate on the scale of
minutes. The same dose of FLASH RT can be delivered in a total time ranging from a
few microseconds to a few hundred milliseconds. This difference holds major positive
implications for patient experience [4]. Secondly, and most important, FLASH RT has
generated much excitement in the radiation oncology community because of its ability to
produce the “FLASH effect” - it is therapeutically more effective than CONV RT.

What is the FLASH effect?
Considering that FLASH radiotherapy is defined by its ability to produce the
FLASH effect, it is imperative to elucidate the actual presentation of this phenomenon. In
the broadest sense, the FLASH effect is defined as reduced surrounding normal toxicity
in response to targeted radiotherapy at extremely high dose rates compared to
conventional dose rates [4]. FLASH elicits a radiobiological effect characterized by equal
therapeutic effectiveness in damaging tumor tissue paired with a desirable decrease in
damage to surrounding healthy tissue. The FLASH effect is achieved by delivering a
radiation dose in a compressed time (milliseconds) at an “ultra-high” dose rate (40 Gy/s
or above) [21]. In chasing this effect, theoretical parameters are becoming more defined
based on increasing incoming evidence. These parameters clarify the physical irradiative
settings that best produce the FLASH effect. For example, one study found that the
FLASH effect was most reproducible with 1-10 pulses, an overall time of <200ms, and a
dose-rate within the pulse of >1.8x10^5 Gy/s. The most evident difference between
FLASH RT and CONV RT is the magnitude difference in the total time of dose delivery
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[4]. There are multiple ways in which this tenet of normal tissue sparing has been
identified in the literature. One study used a metric of spatial memory to indicate the
sparing effect of FLASH in mice. Mice that underwent 10 Gy whole-brain irradiation
experienced spatial memory preservation at 100 Gy/s but not at 0.1 Gy/s [22]. Other
metrics used to corroborate the FLASH effect has been depilation and fibronecrosis in
pig skin; Vozenin et al. have suggested that the FLASH effect could provide 20% greater
healthy tissue protection based on these metrics [23]. FLASH-induced skin pigmentation
has been observed to avoid the skin reaction resultant from CONV RT [4,23] but has not
been used as an analytic metric to quantify the protective effects of FLASH RT. At its
foundation, this thesis will propose and offer the first attempt at just that.

How is FLASH administered?
The scope of this thesis project is primarily focused on basic healthy tissue
response to FLASH vs. CONV radiotherapy. Still, it is vital to develop a functional
understanding of how FLASH RT is possible from a medical physics standpoint. Clinical
linear accelerators (LINACs) are not typically capable of FLASH parameter dose rates
without modification. Thus, for many of the FLASH RT trials in progress, radiation
scientists and medical physicists have resorted to altering experimental LINACs. The
LINACs are changed to be capable of generating a high electron beam current which
allows for the administration of high irradiative dose rates (> 40 Gy/s) via one beam in
under 500ms [3]. One of the significant hurdles facing the FLASH community is
standardizing a common technological platform that facilitates FLASH RT research [21].
Multiple avenues towards achieving this goal have been explored. One of these routes has
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been modifying industrial linear accelerators. In 2018 at Lausanne University Hospital,
Jorge et al. performed a FLASH study using an Oriatron eRT6, a high-dose per pulse
accelerator capable of producing thousands of Gy/s initially designed for industrial use.
The Oriatron allowed for a higher beam current than a typical clinical machine but,
unfortunately, did not have a standard monitoring system [24]. Researchers at the Marie
Curie Institute in Paris have done likewise with a Kinetron [21]. In 2020, Felici et al.
demonstrated that it was possible to alter an Intra Operative Radiotherapy (IORT) mobile
linac into a FLASH-capable research machine. This method was more manageable than
modifying a standard medical linac [21]. In their study, the research team utilized a
standard NOVAC 7 IORT unit and increased its maximum radiation output from 0.65
Gy/s to 540 Gy/s [21]. A major advantage of this mobile clinical linac transformation
method is its “reproducibility and simplicity” [21]. There are multiple avenues for
successfully creating a viable FLASH electron beam. Rahman et al. offer the readily
reproducible and reversible conversion of a clinical LINAC used in the study examined
in this thesis [25].

FLASH RT: Up to Date Literature Review

FLASH Sparing Normal Tissue
Likely the most exciting aspect of all the early-stage FLASH RT literature is its
promise to improve the therapeutic ratio via decreased normal tissue toxicity. This
FLASH effect phenomenon has been documented in many preclinical studies across
various tissue types and test species. As previously mentioned, the pivotal 2014 study
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from Favaudon et al. revitalized preclinical research in FLASH RT after its near 40 year
hiatus. This study examined lung fibrogenesis in mice as its marker for radiative damage
induced by either ultra-high dose rate radiation (>40 Gy/s) or conventional dose rate
radiation (<0.03 Gy/s) [3]. After irradiating 240 mice, the study revealed that FLASH
better protected the mice lungs from radiation-induced fibrosis (development of scar
tissue) and protected the blood vessels and bronchi from radiation-induced acute
apoptosis [3]. Cognitive function has also been investigated as an indicator for irradiative
sparing. One study from Lausanne University Hospital exposed mice to a 10 Gy dose of
whole-brain irradiation at FLASH (100 Gy/s) or convention (0.1 Gy/s). After months of
testing, it was concluded that administering radiation at an ultra-high dose rate correlated
with memory preservation in mice. The CONV RT group exhibited total memory
impairment [22]. In the same cognitive vein but beyond memory, Simmons et al. found
that whole mouse brain irradiation with FLASH was also correlated with reduced
cognitive impairment in the form of object location and recognition tasks. In this same
study, FLASH was also favorably linked with the preservation of dendritic spine density
and less severe neuroinflammation than conventional radiotherapy [26,27]. Moving away
from the brain and across an entirely separate physiological system, FLASH has been
found effective in the gastrointestinal and abdominal sphere. In 2019, Levy et al.
discovered that FLASH RT was correlated with lower mortality from gastrointestinal
syndrome, fewer crypt base columnar cell deaths, as well as preserved gut function and
epithelial integrity [28]. This last metric, FLASH’s impact on epithelial integrity, will be
critical to the overarching argument of this thesis. The integumentary system has also
been investigated in early FLASH RT research. Extremely relevant to the work in this
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thesis, one study found that FLASH was less damaging to pig skin than CONV RT based
on the metrics fibronecrosis (cell death) and depilation (hair loss) [23]. While research
surrounding the phenomena of normal tissue sparing after FLASH RT is not limited to
the aforementioned, the number and variety in these examples suggest that the sparing
aspect of the FLASH effect is likely a genuine occurrence.

FLASH Iso-effective in Tumor Damage
Ultra-high dose rate radiotherapy cannot be taken seriously as a legitimate
candidate for clinical application without proving sufficiently effective at what
radiotherapy is primarily meant to do: damage and kill tumor tissue. While less studied
than the FLASH sparing effect, the consensus is that FLASH RT is likely equally
effective in tumor damage as conventional RT. In essence, FLASH is similarly lethal to
cancer as CONV RT sans considering normal tissue toxicity. Vozenin et al. conducted an
experiment investigating FLASH’s efficacy against squamous cell carcinoma in the nasal
planum of cats. Durable tumor control was accomplished in five out of the six cats
irradiated, which indicated meaningful efficacy [23]. FLASH RT-induced tumor damage
has also been evaluated in nude mice via a human tumor xenograft model. In one 2019
study, human breast cancer (HBCx-12a) tumor xenografts in nude mice were irradiated
with two equal fractions of 17 Gy FLASH and CONV RT.
Additionally, human head and neck carcinoma xenografts were exposed to an
array of radiation doses of either FLASH or CONV. At six weeks, tumor growth was
evidenced to be dose-dependent in FLASH and CONV RT. Moreover, FLASH was
remarkably effective at tumor control. At 25 Gy, FLASH even caused complete tumor
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growth arrest at six weeks [3]. Beyond the realm of xenograft tumors, FLASH also
proved effective in orthotopic mouse lung carcinoma. At 15 Gy, FLASH was found to be
equally as effective as CONV. Impressively, between doses of 23-28 Gy, FLASH
returned to be more efficacious [3]. A separate 2019 experiment demonstrated the same
trend in ovarian cancer peritoneal metastases in mice. FLASH was found just as effective
as CONV in tumor control with no significant differences in the number of tumor nodules
or total tumor weight [28].

First Human FLASH RT Patient
While the scope of FLASH RT research is largely yet to break preclinical
boundaries - research typically comprises murine, canine, and porcine models - there has
been one verified human case of cutaneous lymphoma treated via ultra high dose-rate
radiotherapy [29]. Discerning that demonstrated iso-effective tumor damage and
improved normal tissue sparing in FLASH preclinical research prompted a clinical
translation, researchers and medical professionals at the University of Lausanne
conducted the first-ever clinical FLASH irradiation treatment to a human patient. The
patient, a 75-year-old man with multiresistant CD30+ T-cell cutaneous lymphoma, had
received over 110 localized radiotherapy treatments for various skin lesions in addition to
system treatments before FLASH. This local and conventional radiotherapy administered
to the patient between 2008 and 2018 effectively controlled targeted tumors.
Unfortunately, the surrounding tissue tolerance was often inadequate or very poor and
regularly resulted in a 3-4 month healing process for any 3-4 cm skin lesion. Thus, when
the patient presented with a 3.5-cm diameter skin lesion in 2018, the Lausanne medical
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team determined that FLASH RT might offer equivalent tumor control while minimizing
toxicity to the surrounding healthy tissue. In turn, a 5.6-MeV linac designed for FLASH
administered 15 Gy in 90ms to the PTV.
The results were promising for clinical FLASH. The patient incurred follow-up
appointments for a sustained time after irradiation. At three weeks, maximal surrounding
normal tissue reaction presented with both grade 1 epithelitis and transient grade 1
oedema. However, OCT scanning demonstrated no decrease in epidermal thickness nor
disruption of the basal membrane. Just as encouraging, tumor damage was complete,
durable, and rapid. The lesion began shrinking on day ten and completed its response by
day 36. The tumor exhibited a durable response at the 5-month follow-up.
While one successful account of FLASH RT in the clinical setting, candidly, does
not warrant any staunch conclusion on the efficacy and viability of FLASH, it does point
to several favorable inferences. Firstly, this initial clinical implementation of FLASH
provides confidence to the medical community in the technical feasibility of FLASH ultra
high dose-rate radiotherapy. The treatment also evidenced the clinical safety of FLASH.
Furthermore, and most importantly, the patient in this clinical treatment exhibited a
response to the FLASH irradiation consistent with what was expected from preclinical
research of the FLASH effect [29].

The Mystery Behind the Mechanism
As described, the benefits of the FLASH effect have been observed across various
preclinical and even one clinical model. However, to appropriately incorporate any
medical technique into the clinical setting, it is essential to understand the underlying
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biological mechanisms in place that allow it. Several mechanistic pathways behind the
FLASH effect have been suggested. Although, the objective natural reasoning for why
normal tissue is better spared through ultra-high dose rate radiotherapy is largely up for
debate, and conclusions are far from definitive. Three popular mechanistic theories hold
the forefront in conversation: oxygen depletion, DNA damage, and immunological
response [30].

FLASH Mechanism Theory 1: Oxygen Depletion and Reactive Oxygen Species
Multiple studies have suggested that the mechanism behind the FLASH effect
could be rapid local oxygen depletion which might cause transient radiation-induced
hypoxia [4]. The ultra-rapid delivery of radiation may deplete oxygen levels and void
normal tissues from reoxygenation which, in turn, increases their resistance to ionizing
radiation [30]. This type of radiochemical event has been aptly identified and described
since as early as 1959 through Serratia Marcescens bacterium. Dewey et al. report,
“many biological materials prove to be more radiosensitive when under higher
concentrations of oxygen.” The phenomena held for Serratia Marcescens when cultures
irradiated at higher oxygen concentrations demonstrated poorer survival rates in the face
of high dose rate radiation [31]. In a later study by the same group, fully aerobic bacteria
were found to be less sensitive to radiation at low dose rates than at high dose rates [32].
While radiation-induced hypoxia may provide improved radioresistance for normal
tissue, tumor tissue is not as heavily affected due to its already abnormal vasculature and
oxygen supply [30]. Thus, tumor tissue is not as impacted and does not experience the
same increases in radioresistance.
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FLASH Mechanism Theory 2: Variation in DNA Damage Response
DNA is widely accepted as the primary site of radiation-induced cell damage.
Ionizing radiation causes various lesion types in cellular DNA, but double-stranded DNA
breaks are most heavily associated with radiation cell killing [33]. Healthy cells are
generally faster and more precise than tumor cells in their DNA repair kinetics: this
principle is the fundamental basis behind hypofractionation radiotherapy [30]. FLASH
RT may induce an even more significant disparity between normal and cancerous DNA
repair kinetics, contributing to the FLASH effect. This exact difference has not yet been
quantified. However, there has been evidence of inherent differences in DNA response to
FLASH versus CONV RT. Preliminary results suggest that FLASH RT might result in
lower DNA double-strand break yield in normal tissue and generally more clustered
DNA damage among other DNA-related deviations [30]. Importantly, none of these
findings are particularly conclusive but do warrant further study.

FLASH Mechanism Theory 3: Immunological Response
Another possible theory underlying the FLASH effect is a varied immune
response to FLASH versus CONV RT. In CONV RT fractionated radiotherapy regimes, a
higher percentage of circulating lymphocytes are irradiated. In turn, more chromosomal
aberrations are produced [34]. Following this logic, the short duration time of FLASH RT
would result in fewer chromosomal aberrations and, thus, less collateral healthy tissue
damage [34]. One study that investigated mice's immune response to FLASH vs. CONV
RT through a genome microarray analysis found that immune system activation and
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maturation decreased following FLASH compared with conventional RT [35]. Moreover,
one research team demonstrated that FLASH RT recruited more T lymphocytes into the
tumor microenvironment than conventional radiotherapy [36]. It is critical to note that the
immune response to FLASH RT is just that, a response. Thus, the immune response itself
cannot be considered the causal factor producing the FLASH effect. That said, a varied
immune response could potentially be an explanation for why the FLASH effect is
present.

Feasibility of Clinical Translation
According to a critical 2019 review of FLASH RT research to date, “the
consistency of the normal tissue protection among species, the magnitude of this benefit,
and the excellent anti-tumor effects observed so far, all suggest that the FLASH effect
could also be reproduced in human patients and encourage the testing of this hypothesis
in clinical trials” [4]. One of the most promising aspects of modern FLASH research is
that the normal tissue sparing effect had been observed across four separate species
models: zebrafish, mouse, mini-pig, and cat [4]. And more recently, through the work of
Dr. Jack Hoopes at Dartmouth College, a canine model also exhibits the FLASH effect.
Moreover, the sheer magnitude of normal tissue sparing derived from FLASH RT is
impressive as well. In a study exploring the impacts of FLASH RT on larger mammals,
pig skin was used to investigate the normal tissue toxicity differential between FLASH
and CONV radiotherapy. While evaluating depilation and fibronecrosis as markers for
toxicity, FLASH RT was more than 20% more protective [23]. This pig model is
particularly reassuring because pig and human physiology are considered very close [4].
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Another observation suggesting the viability of FLASH RT’s transition into the clinical
setting is that FLASH RT is shown to be iso-effective in terms of tumor damage as
CONV RT [4]. As explained, this anti-tumor efficacy has been corroborated across
multiple, varying mouse models - xenograft, orthotopic, transgenic, etc. - as well as
across a diverse array of tumor types, including breast, lung, ovarian, and brain [4].
Ultimately, there are two general purposes that FLASH would serve if incorporated into
the clinical setting. Firstly, FLASH would allow the total dose to increase against
typically radioresistant tumors associated with poorer outcomes. Secondly, FLASH
would improve cases where radiotherapy offers reasonable tumor control but is currently
contraindicated because of severe normal tissue toxicity [34]. While there is plenty of
evidence suggesting that clinical translation of FLASH RT could be feasible soon, more
research needs to be completed. The call for more research rings especially true in light
of the porcine model examined in this thesis which, while contained to the scope of only
one mini-pig, does not necessarily corroborate the current literature around FLASH RT.

Pigmentation as an Indication of RT-Induced Damage
There are multiple limitations to FLASH RT in its current state. Firstly, there are
many crucial beam and treatment parameters that current literature has not yet fully
investigated. Clear observations, as cited, have been made about dose rate and the overall
duration of irradiation. Clarity surrounding the contributions of dose-per-pulse, pulse
duration, dose-per-pulse divided by dose duration, and pulse frequency have yet to be
unraveled. [21]. Further, not all forms of standard irradiation techniques are available in
FLASH. FLASH RT is largely limited to high-energy electron and photon irradiation.
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Over the past few years, most FLASH studies have utilized modified electron linear
accelerators [37]. While exciting in the preclinical setting, these experimental beams are
currently strictly limited to relatively superficial treatment areas due to limited depth
penetration [37]. Other forms of radiation administration, such as Proton Beam Therapy,
might be more applicable in the FLASH RT setting in the future. However, admittedly,
the outlook on the efficacy of FLASH protons inducing the FLASH is mixed [37]. For
the foreseeable future, FLASH seems to be relegated to a depth of only a few centimeters
due to the 4.5-20 MeV window allowed by the machinery [34]. This depth limitation
suggests that the integumentary system and its various modes of response to FLASH RT
will be critical to understanding FLASH RT in the foreseeable future. This thesis, in large
part, suggests that skin pigmentation ought to be utilized as a non-invasive yet
quantifiable marker for radiation-induced skin damage. Differences in RT-induced skin
pigmentation across FLASH and CONV have been observed in the literature [23]. Still,
they have not yet been considered seriously as a quantifiable metric for radiation-induced
tissue damage. We hypothesized that skin pigmentation - the increase of epithelial
melanin - would be correlated with radiation-induced damage in the form of epithelial
thinning. Moreover, we hypothesized that FLASH RT would elicit less of a skin reaction
than CONV Rt and, thus, less epithelial thinning damage. While the results corroborated
the aforementioned portion of our hypothesis, we did not expect to see that FLASH RT
triggered a more severe skin reaction than conventional RT. This finding, while troubling
for the case of FLASH RT, certainly has its limitations. Regardless, skin pigmentation is
evidenced to be a valuable metric for future FLASH RT research.
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METHODS:

Experiment Overview
A porcine model experiment was developed to better understand the effect that
FLASH ultra-high dose rate radiotherapy has on healthy animal tissue and potentially
corroborate growing evidence that FLASH RT has a sparing effect for normal, nontumorous tissue. One female Yucatan mini-pig - officially labeled the Sus scrofa
domesticus - was used for this multi-month study. On the day of irradiation, the pig was
212 days old and weighed 27 kg. Eight distinct 3cm diameter circles, each separated by at
least 4cm, along the dorsal side of the pig back were identified as areas of interest. As
seen in Figure X, four circles were designated for FLASH RT testing along the left dorsal
of the Yucatan mini-pig. Additionally, four circles were set for CONV RT testing along
the left dorsal of the Yucatan mini-pig. From cranial to caudal, circles follow the
designations of 0 Gy (control), 20 Gy, 30 Gy, and 40 Gy of irradiative doses.
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Image 1: Pig Day 0
Image of the unirradiated pig on day 0. On the pig’s left (top) flank, four
3cm circles were drawn as the FLASH irradiated ROIs. On the pig’s right (bottom),
four 3cm circles were drawn for conventional RT. From cranial to caudal (right to
left), the doses respectively follow 0, 20, 30, and 40 Gy.

A clinical linear accelerated (LINAC) was used to irradiate the designated
conventional ROIs. The LINAC was then converted according to Mahbubur et al.'s
procedures to irradiate the FLASH designated areas [25].
The pig subject’s response to irradiation was monitored over the course of 32
days, from March 19th to April 19th. Standard RGB images were taken on 18 of those
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days. Those images were then analyzed to quantify exact changes in skin pigmentation in
a self-coded MATLAB App Designer application. Histology staining was performed on
day 26, after surgical biopsy on day 26. These histology slides were then used to make
epithelial thickness and melanin measurements through software-aided microscopy and
another self-written MATLAB App designer app. OCT imaging was performed both on
day 0 and day 26, and epidermal measurements were made to inform the co-registry of
data.

Animal Use Protocol
Implementing a porcine model for studying the effects of FLASH irradiation on
normal, healthy tissue was warranted for several reasons. The comparison between
conventional radiation dose rate and flash radiation dose rate is difficult to justify in
humans due to efficacy and safety concerns. This study aimed only to investigate the
effects on normal skin only and not on tumor tissue. Pig skin is similar to human skin
with similar epidermis and dermis regions and a kindred regeneration time of epidermal
cells (~30 days for a pig, and 27-28 days for a human) CITATION. Pig skin has often
been used as a model for wound healing, transdermal delivery, radiation effects, etc., due
to its similar structure, characteristics, and responses to human skin. Pig skin allowed for
a translational comparison of normal tissue effects post FLASH and CONV radiation.
The Yucatan mini-pig was irradiated (superficial skin only) in multiple lateral flank and
thoracic regions. Four locations were designated for conventional RT, and four were
selected for FLASH RT. The irradiated and control zones were marked with semipermanent skin markers regularly used in radiation oncology. Using the irradiator light
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field as a guide, we marked the irradiated zone and 0.5 cm radius larger circumference
around the irradiated area. Various drugs were used to irradiate and analyze the pig
humanely. These drugs included pre-anesthetics such as ketamine and midazolam,
anesthesia for surgery and OCT imaging, as well as ketoprofen and xylocaine for pain
control. All surgical procedures followed the sanctioned IACUC protocol. The pig was
monitored post-irradiation for skin damage and signs of morbidity such as weight gain,
weight loss, behavioral changes, and abnormal physiological activity daily.

LINAC Conversion
Modifications were performed on the clinical LINAC to deliver high-energy
electron beams by electing a 10 MeV photon beam in the treatment console. Next, the
medical physicist removed the target and flattening the filter from the beam trajectory.
The changes required the hand-operated setting of multiple critical elements of the
treatment distribution system: the carousel, air valves, and the target. The carousel of the
treatment head contains flattening filters and scattering foils. Flattening filters and
scattering foils are used in conventional radiation therapy for uniform dose distribution
and dramatically reduce the dose rate - not ideal for FLASH RT. The carousel was
arranged so that the 20 MeV port cover was readily removed. Afterward, the carousel
was returned to its original position. The entire electron beam conveyor system from the
electron rifle through the accelerating waveguide, bending magnet, destination, and exit
window is under vacuum to arrest the scattering of the electron beams. Physical
adjustments to the system are pneumatically actuated and controlled by the air valves.
The LINAC was hand adjusted to deliver high-intensity proton columns by turning off
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the air drive. The target actuator and positioning device had three modes: low-energy xray mode, high-energy x-ray mode, and electron mode. The target device was manually
forced to electron mode to deliver UHDR electron columns. This setting was temporarily
fixed. In conventional mode, beam parameters are regulated by the LINAC through
feedback loops. They ensure the beam mold and strength are within a specific tolerance
of normal conditions. That said, after adjusting the LINAC, the servos are programmed to
expect a standard beam and counterbalance for the differences. These automatic changes
could be damaging to the FLASH beam performance, so the steering and dose-rate servo
activities were switched off.
Additionally, the dose servo was turned off. Interlocks linked with the handoperated modifications of the LINAC were overridden. The conversion back to
conventional mode was managed by performing the described steps in reverse [25

Dosimetry
Because of its excellent dose rate and energy sovereignty, in both conventional
and FLASH RT, Gafchromic Film EBT-XD was utilizes as the dosimeter in this
experiment. The EBT-XD film affords a strong dynamic and minimizes other
uncertainties associated with normal film dosimetry, including orientation outcomes and
sidelong response artifacts. The Gafchromic film was then digitized on an Epson
11000XL flatbed scanner with a 48-bit depth alongside a resolution of 96 dots per inch.
The machine’s capacity to administer FLASH RT and other major beam parameters, such
as beam profiles, percentage depth dose, and beam balance, were quantified using this
film and the data obtained from it. The team performed all dosimetric measurements at
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the isocenter. They did so 360 times each second. The values were confirmed by
measuring at least three times unless indicated otherwise.

Table 1: Dosimetry
Prescribed and true doses of FLASH and conventional RT
administered to each region of interest on the pig. True doses
were confirmed with Gafchromic film placed directly on top of the
pig skin.

Image Analysis
Skin Image Analysis: Image Obtention
In order to assess changes in skin pigmentation induced by varying levels and
modes of irradiation, standard truecolor images were regularly taken of each irradiative
and control circle throughout the study. The same individual took all of the photos with
the same iPhone 8 Plus. Every iPhone 8 Plus operates dual 12MP cameras - one wide and
one telephoto - with a six-element lens. The two cameras provide f/1.8 and f/2.8
apertures, respectively. All images were taken in the standard photo setting without flash.
Once the images were taken, they were initially saved as JPEG files. Ultimately the
images were then cropped with the MacBook Pro screenshot tool and, thus, re-configured
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to be on a classic RGB (0-255) color scale with the MacBook Color LCD color profile.
The DPI (dots per inch) for all images was 144 pixels/inch. It is crucial to note that while
the pictures taken are undoubtedly usable for pigmentation assessment, the plan for
image analysis via MATLAB was constructed after half the images had already been
taken. In turn, while there was a concerted effort to make each image clear, in focus, and
without blatant shadow interference, there was no precise control for lighting or other
factors. The shortcomings of the imaging data were, in large part, mitigated by the logic
of the MATLAB app created for the analysis.

Skin Image Analysis: Pigmentation Quantification via MATLAB App Designer
Various qualitative ranking systems are commonly practiced to assess
physiological phenomena like pigmentation, desquamation, etc. However, it was
necessary for this study to objectively quantify the exact amount of change in
pigmentation at each test and control site of the pig. It was critical to distinguish nuances
of pigment fluctuation and better inform the co-registry by combining the pigment pixel
data with the OCT and histology data findings. In order to carry out this quantitative
analysis on data which before was only qualitative, an interactive application was created
through MATLAB app designer.
The final iteration of the application was just over 500 lines of code and combined
an easy-to-use user interface with a logical analysis script. The verbatim code is attached
in the appendix. The application is composed of thirteen separate app components. Six of
the app components either serve to improve the visual layout of the app, user instruction,
or app startup and do not warrant further explanation. These components include UI
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Figure, TabGroup, ImageEvaluationTab, SpecifyDatePickerLabel,
SpecifyDataTypeDropDownLabel, and TextArea_2. The other seven components are
integral to the logical function of the image analysis. These components include the
UploadImageButton, SpecifyDatePicker, SpecifyDataTypeDropDown,
AnalyzePixelsButton, UITable, UIAxes, and SelectxlsxButton.
The SelectxlsxButton permits the user to choose any already created excel file
from their computer to which they wish to upload the pixel analysis data. The
UploadImageButton allows the user to select an image for analysis from their device.
This image is saved for use in the AnalyzePixelsButton and displayed for the user’s
confirmation of a successful upload onto the UIAxes component. The SpecifySatePicker
allows the user to select a date of when the image was taken. The
SpecifyDataTypeDropDown enables the user to choose between the various modes and
levels of irradiation used in the study. The app configured in this project is tailored for
this particular porcine model with both FLASH and CONV 0, 20, 30, 40 Gy provided in
the drop-down menu. That said, these options can be very readily modified to fit the data
type for any subsequent studies. The UITable affords the visual representation of the
excel data selected. Finally, and most importantly, the AnalyzePixelsButton is the
functional piece of the application that ultimately creates the data values. All of these
operations can be seen in Figure X below.
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Image 2: App #1 - Skin Pigmentation Quantification
MATLAB Imaging App specifically written to quantify changes
in skin pigment from RBG iPhone images. The app, composed of
511 lines of code, allows for interconnectivity with a local excel file,
image uploading, date and data type specifications, as well as a
fully functional analyze pixels button.

After selecting the .xlsx file, image of interest, date, and data type, the user
presses the AnalyzePixelsButton. Pressing this button creates a standard pop-up
MATLAB figure which comprises the one picture which was previously selected. The
user is automatically prompted to distinguish twenty separate areas of interest on the
image. The first ten areas must be reference areas that reside just outside the designated
circle. The second ten areas are test areas; they are inside the ring and are eventually
tared against the reference areas. This process is visualized in Figure X. The areas are
rectangles drawn by the user via the imcrop function from the MATLAB library.
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Image 3: App #1 - ROIs
Example of image cropping for pixel analysis. 10 reference
rectangles are selected outside the circle. 10 test rectangles are
selected inside of the circle. All ROIs are selected with the
intentional avoidance of skin blemishes, previous pigment spots,
and ink.
The region of interest (ROI) rectangles were selected based on the following
protocols. Every rectangle was identified on the first day to represent normal pink pig
skin best. Given that this was a pixelated color analysis, it was essential only to analyze
particular skin areas which were not impeded by dark imperfections, birthmarks, moles,
or other blemishes. Multiple irradiated circles contained said dark blotches - namely
FLASH 0 and 30 Gy and CONV 30 Gy. We intentionally did not include the blotched
portions within these circles in our regions of interest. The same protocol was followed
for circles with dark blotches just outside in the reference areas - namely FLASH 0, 20,
and 40 Gy, as well as CONV 0, 20, and 30 Gy.
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Once all twenty rectangular areas of interest are designated, the cropped images
are sent into the logic of the application’s image analysis script. First, all twenty cropped
images are converted from RGB to Grayscale via the MATLAB function rgb2gray. Each
cropped area of interest image is then averaged via the MATLAB function, mean, to
obtain the mean grayscale intensity value. Subsequently, each mean reference value is
analyzed against each mean test value to assess for contrast. These reference areas
essentially acted as a “tare” against undesirable shadow variation. The equation to find
contrast:
Contrast = (TestValue - ReferenceValue) / ReferenceValue
Equation 1: Contrast Evaluation Equation
Since every test and reference value are jointly inserted into this equation, for
every image analyzed, there are 100 contrast values produced. The average and standard
deviation are then extracted from these 100 contrast values via the mean and std functions
in MATLAB. The same process is carried out, minus to rgb2gray step, to assess for red,
green, and blue values separately. However, the specific, non-grayscale RGB data was
not analyzed further or considered in the results of this project. The final raw data file
was an 18x145 .xlsx file.
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Image 4 + 5: App #1 - RBG to Grayscale
Conversion of RGB Image to Grayscale via rgb2gray
MATLAB function.
After all of the raw imaging data was collected, excel was used to normalize, fit,
and visualize the data. The data were normalized according to the equation below, where
day 0 refers to the March 19th value of the given dose (0, 20, 30, or 40 Gy) and modality
(FLASH or CONV).

Equation 2: Skin Pigmentation Ratio Metric

A polynomial, 5th order trendline was then created via the automated excel
software to better visualize the trends of each radiation dose over time. The values of the
normalized data - which result from the 100 averaged contrast values - mark the creation
of an original “Skin Pigmentation Ratio” metric that can be used in future similar
studies.
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Histology Staining
Twenty-five days after irradiation, biopsies were taken from each of the eight 3cm
flank regions. The samples were fixed overnight in 4% neutral buffered formaldehyde.
Research Pathology Services at the Geisel School of Medicine at Dartmouth College
prepared histopathology and immunohistochemistry tissue sections. Formalin-fixed
tissues were dehydrated using alcohol, cleared with xylene, and embedded in paraffin.
The tissue samples were cut to the 4-μm thickness and dyed with hematoxylin and eosin
(H&E). In order to corroborate any results from the above-described skin imaging
technique, it was essential to gain insight into skin pigmentation via the gold standard of
tissue analysis: histology. The tissue samples were also cut to the 4-μm thickness and
stained via a Fontana-Masson histochemical stain. For both the H&E and FontanaMasson histochemical stains, each of the eight doses came back with four sections of
tissue for analysis.

Melanin Histology Analysis
Using an OlympusBX50 microscope, between 15-20 sections of each tissue by
dose were imaged for further analysis. Image X illustrates a typical image of this stain
type. Dark-colored blotches indicate the presence of melanin along and within the
epithelial layer.
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Image 6: Original Melanin Histology
Example of an image from under the OlympusBX50
microscope of the Fontana-Masson histochemical melanin stain.
Dark blotches along the epithelial layer confirm the presence of
melanin. This image comes from the FLASH 40 Gy biopsy region.

To quantify and co-register the skin pigmentation image analysis with the melanin
levels in the histology, the aforementioned MATLAB app was modified to accommodate
a second form of pigmentation analysis based on this melanin stain. And, thus, a second
application was created. The visual modifications, which were few, can be seen in Figure
X. While the Melanin Quantification App looks almost identical to the Skin Pigment
Quantification App, the quantification algorithms and functionality underlying each is
very different.
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Image 7: App #2 – Epithelial Melanin Quantification
The Melanin Quantification App holds a near identical layout
to the Skin Pigment Quantification App. The data saved to the
excel sheet is formatted differently as illustrated in the column
headers. The melanin app, however, is significantly different in its
underlying analysis algorithm.
While many melanin patches are evident to the human eye in a Fontana-Masson
stain, some pockets of melanin are harder to detect. Moreover, the lack of RGB value
spread in the original histological images makes it very difficult for a computer image
analysis to differentiate between melanin and non-melanin tissue. This fact can be
visualized via RGB histograms in Figure X as well as the RGB scatter plot in Figure X,
which both illustrate the original preliminary RGB values from Image X.
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Figures 1,2,3: Melanin Histology Histograms
Three histograms of the red, green, and blue pixel values of
the original 10x magnification melanin stained histology tissue. In
all three figures, the peaks are bunched. This small spread makes
image analysis difficult and calls for a contrast stretch.

39

Figure 4: Melanin Histology Scatter Plot
A 3-dimensional scatter plot of the three RGB histograms of
an original melanin stain image. Important to note: the scatter plot
is heavily concentrated. Clumping of RGB values makes the
differentiation between melanin and non-melanin pixels difficult
during image analysis.

The RGB value clumping served as a roadblock to automate melanin pixel
identification. Thus, we performed a much-warranted contrast stretch to spread the pixel
values and make the threshold between melanin (lower values) and non-melanin (higher
values) more readily identifiable. The MATLAB function, imadjust, was used to
accomplish this. The image was stretched entirely across the 255 value system of the
visible RGB spectrum. This image stretch resulted in RGB values, which were
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proportional to the original photo and much more accessible in terms of melanin
identification. Figure X and Figure X below illustrate the RGB value stretching which
occurred.

Figures 5,6,7: Melanin Histology Stretched Histograms
Three histograms of the red, green, and blue pixel values of
the contrast stretched 10x magnification melanin stained histology
tissue. In all three, the RGB values are spread apart which makes
melanin quantification more readily accessible.
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Figure 8: Melanin Histology Stretched Scatter Plot
A 3-dimensional scatter plot of the three RGB histograms of
the stretched melanin stain image. Important to note: the scatter
plot is no longer heavily concentrated. The values are spread
across the 0-255 spectrum which makes the melanin/non-melanin
threshold easier to identify in image analysis.
The image stretching, as mentioned earlier, resulted in a much different looking
image, which can be seen in Image X. Although, it is significant to note that because the
stretching maintains a relative distance between the RGB values, the melanin data in the
new contrast stretched image retains the valuable melanin data. However, it holds this
data in a more accessible form because of the broader difference between melanin and
non-melanin RGB values.
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Image 8: Contrast Stretched Melanin Stain
Example of post-contrast stretched image used in App #2.
The image above is a version of the same image as shown
previously. It is from of the FLASH 40 Gy biopsy region.
Based on a visual evaluation of multiple contrast stretched images, it became
clear that the areas of epithelial melanin held average RGB values ~25 and below. Thus,
the newly extended images were converted to a binary with a threshold of 0.1 maximum
color value. The threshold essentially means that any pixels with average RGB values 25
and under were converted to a 0. Conversely, any pixels with average RGB values of 26
and above were converted to a 1. This conversion carried out with
the rgb2gray and imbinarize functions sequentially resulted in precise isolation of easily
visualized melanin data, as seen in Figure X.
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Images 9+10: Contrast Stretch, Binarized Melanin Histology
A contrast stretched melanin stain image (left) and the
subsequently binarized version at the 10% average RGB value
threshold (right). The binarized, black and white, image shows only
melanin areas in black.
After binarization, every melanin pixel in the image held a value of 0, and every
non-melanin pixel held a value of 1. Thus, in order to quantify the amount of melanin in
the epithelial sans keratin layer, the two images were overlaid so that the epithelial ROI
could be identified on the contrast stretched image. Subsequently, the actual data
processing algorithm was actuated on the binarized image. To do this, the MATLAB
Melanin Analysis App utilized the draw freehand function, as seen in Figure X.
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Image 11: App #2 – ROIs
The contrast stretched image in front allows for accurate
drawing around the epithelial layer - seen in blue - which analyzes
the same area of the binarized image underneath.
The actual melanin quantification after this point was a simple black to total pixel
percentage. The number of black pixels (with values of 0) identified in the epithelial layer
of the binarized image was divided by the number of total pixels (1s plus 0s) in the
epithelial layer. The calculation was performed for every histological section of all eight
doses. The percent melanin values were then averaged across each dose.
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H&E Histology Analysis
Under an OlympusBX50 microscope, ROIs of the irradiated normal tissue were
analyzed at ×10 magnification co-currently with the microscopy analysis
software, touplite. We obtained two types of measurements across the epidermal layer:
epidermis san keratin and epidermis with keratin. For the epidermal layer (not including
the keratin layer), 1,828 measurements were made under the microscope, as seen in
Figure Xa. For the epidermal layer (including the keratin layer), 1,124 measurements
were made under the microscope, as seen in Figure Xb.

12

13)

Images 12+13: Epithelial Histology Measurements
12) Example of histology measurements across the epidermis
excluding the keratin layer. 13) Example of histology
measurements across the epidermis including the keratin layer.
Epidermal thickness averages were then calculated for epidermis as well as
epidermis + keratin modes. Additionally, the keratin layer was assessed by itself by
subtracting the two aforementioned modes. Ultimately, only the epidermal layer san
keratin layer returned valuable information, so only it will be included in the results
section.
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OCT Imaging
On Day 26, the pig was imaged using a swept-source Optical Coherence
Tomography (OCT) machine. The system's light source was a 20 kHz rotating-polygonbased tunable filter. The filter was programmed to hold a wavelength at 1320 nm and a
comprehensive sweep range of 110 nm. Its average power output was ten mW. For the
OCT imaging process, the pig was anesthetized and placed under the imaging probe.
Imaging was performed in conventional OCT speckle variance (svOCT) mode to obtain
microvascular images of the animal tissue. Ultimately, eight microstructural images were
taken from the same location within a 25 ms interval. Microvascular images were
converted to the RGB color space on a standard 0 to 255 color scale for better data
visualization. Matlab software was used to prepare and reflect the data. Micrometer
epidermal thickness measurements were then made using Thorlabs Imaging Systems
software. Twenty-five measurements were made for every 3mm of image. Finally, all the
thickness values were averaged to find a representative epidermal thickness value.
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Image 14: OCT Measurements
Example of OCT epidermal thickness measurements made
in Thorlabs Imaging Systems software.
layer.
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RESULTS

Skin Pigmentation Images

Results
Using the Skin Pigmentation Quantification App created in MATLAB App
Designer, all 144 images of the eight regions of interest over the 31 days were analyzed.
Assessing for changes in pixel contrast between the outer and inner circles over time, we
were able to quantify what we could see with our eyes accurately. Consider Figure X.
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Figure 9: 3 Day Case Skin Study
Three day case study of radiation-induced pig skin
pigmentation reaction over time. Days 0, 18, and 27 are labeled
across both modes of RT - FLASH and CONV - as well as all four
dose levels - 0, 20, 30, and 40 Gy. Prescribed and actual doses,
which differ slightly, are articulated on the right.

Assessing only with the eyes, it is clear that the eight regions of interest
responded proportionally to the overall dose. Changes in the FLASH and CONV 0 Gy
regions are essentially not detectable. The CONV 20 Gy region darkened slightly only by
day 27. The CONV 20 and 30 Gy regions shaded slightly by day 18 and the change
between day 18 and day 27 is not readily identified. The FLASH 20, 30, and 40 Gy
regions darkened slightly by day 18 and darkened significantly by day 27. Using a
qualitative analysis is helpful but not sufficient for this data nor convincing the scientific
community. As explained, it is for this reason that the first MATLAB application was
created. Using the skin pigmentation quantification app in MATLAB App Designer,
exact changes in pigment levels could be evaluated and visualized via pixel data. The
quantified data can be visualized below in Figure X.
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Figure 10: Skin Pigmentation Plot
Raw data points of quantified skin pigmentation data using
the MATLAB App Designer Application. Standard error bars are
determined from the 100 contrast values generated between the
10 test and 10 reference regions for every image.

For a more digestible visualization of the baseline skin pigmentation image data,
consider Figure X.
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Figure 11: Skin Pigmentation Plot with Lines
Raw data points of quantified skin pigmentation data using
the MATLAB App Designer Application with straight lines drawn
between the data points of each series. Standard error bars are
determined from the 100 contrast values generated between the
10 test and 10 reference regions for every image.

Finally, to accurately visualize the interpolated trends amongst the testing levels,
consider Figure X.
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Figure 12: Skin Pigmentation Plot with Interpolation
Raw data points of quantified skin pigmentation data using
the MATLAB App Designer Application paired with interpolated 5th
degree polynomial lines drawn for each of the eight testing levels.
Standard error bars are determined from the 100 contrast values
generated between the 10 test and 10 reference regions for every
image.
Considering the trend lines interpolated and overlaid on Figure X, the exact
quantifiable differences in pigmentation between each testing case becomes clear.
Radiation-induced skin pigmentation changes returned proportional to the overall dose
for both FLASH and CONV modes of irradiation. In other words, for both FLASH and
CONV, 40 Gy elicited the strongest reaction with the most skin darkening, followed by
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30 Gy, then 20 Gy, then the control. It is also evident that FLASH RT produced a
significantly stronger reaction in skin darkening than CONV RT. By day 31, the final day
of analysis, FLASH 40 Gy returned a reaction more than twice as severe as CONV 40 Gy
regarding skin pigmentation. On day 31, FLASH 30 Gy’s pigment reaction was >60%
worse than CONV 30 Gy. FLASH 20 Gy had only an ~18% stronger reaction than
CONV 20 Gy. The control regions returned effectively the same.

Limitations
It is important to note that there were certain limitations to the study's skin
pigmentation image quantification. Most notably, the idea of orchestrating a pixel
analysis was constructed after the initial imaging occurred. As a result, while images
were generally taken in the same lighting with the same camera, no official or specific
protocol was followed for taking the RGB images of the pig skin. Thus, the image data is
not as controlled for shadow as might be desired. This image-taking protocol to control
for shadow will be essential for the next time around.
Additionally, dark skin blotches impeded some of the analysis and forced the
evaluation of each circle to be slightly different as a result. Although, this limitation
likely did not impact the results significantly. Finally, the pig subject is, after all, a pig. It
naturally accumulates dirt, straw, etc., on its skin at times. While not majorly concerning,
this dirtiness certainly could have impacted the artificially darkened some of the analyzed
regions.
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Melanin Histology
Results
Using the Epithelial Melanin Quantification App, created in MATLAB App
Designer, all 147 images of the eight regions of interest over the 31 days were analyzed.
As explained, we assessed for percent melanin by contrast stretching, binarizing, and then
analyzing the stain images. This process can be seen below in Image X.

Image 11: App #2 – ROIs (Repeated)
The contrast stretched image in front allows for accurate
drawing around the epithelial layer - seen in blue - which analyzes
the same area of the binarized image underneath.
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Ultimately, over 143 million pixels were analyzed in the epithelial regions of the
images to return 147 values as visualized in the scatter plot in Figure X.

Figure 13: Epithelial Melanin Box and Whisker
Box and whisker plot of epithelial melanin concentration on
day 26 after irradiation with both FLASH and CONV RT at 0, 20, 30
and 40 Gy.
In order to make the melanin histology data more digestible, we averaged,
evaluated standard error, and collected it into the telling bar plot shown in Figure X.
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Figure 14: Epithelial Melanin Bar Plot
Bar plot of epithelial melanin concentration 26 days after both
FLASH and CONV RT at 0, 20, 30 and 40 Gy. Standard error bars
were calculated from the 15-20 percent values for each dose level.

The percent melanin in the epithelial layer in the control regions was 1.25% on
average. This value serves as a reference point for how much melanin is found without
radiation-induced increase. The eye can identify the two trends evident in RT-induced
melanin recruitment from Figure X. First: melanin concentration generally increased with
dose levels for both FLASH and CONV RT. Admittedly, there was a 0.11 percent dip
from CONV 20 to CONV 30 Gy, as well as maintenance of melanin concentration
between FLASH 30 and FLASH 40 Gy. Regardless, the general trend is still readily
apparent. The second evident trend is that FLASH RT induced significantly more
melanin concentration in the epithelial layer than CONV RT across all dose levels. At 20
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Gy, FLASH recruited 55.3% more melanin than CONV. At 30 Gy, FLASH recruited
77.3% more melanin than CONV. And at 40 Gy, FLASH recruited 21.5% more melanin
than CONV.

Limitations
It is significant to note the inherent limitations of the epithelial melanin
quantification analysis to accurately assess the validity of our findings. The biopsies
resected for histological analysis could have included the dark blotches of skin within
some regions of interest. This compromising tissue resection may have been the case for
the FLASH 0 Gy region, which, for example, has a large dark blotch within the test
region and ultimately presented with a melanin concentration somewhat higher than
expected. As far as the digital analysis portion goes, there were likely two sources of
potential, although not likely significant, errors. Firstly, the area which is drawn around
the epithelial layer inevitably must take on some error. Without the eye of a trained
pathologist, delineation around the epithelial layer was judged by an undergraduate
student. Second, the 10% pixel value threshold chosen for the binarization of the contrast
stretched images could have left some melanin out of the analysis. The 10% threshold
was determined based on what visually represented the melanin best across a sample of
the images analyzed. However, this designation was not perfectly exact. This source of
error likely produced negligible contributions to the final melanin data.
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H&E Histology
Results
In an effort to understand and potentially establish a correlation between skin
pigmentation, epithelial melanin recruitment, and changes in the thickness of the
epithelial layer, we analyzed a hematoxylin and eosin (H&E) histology stain. The biopsy
retrieved for the H&E stain was resected on day 26 after irradiation. The surgery for the
H&E stain was executed on the same day as the melanin stain analysis. The same can be
said for OCT imaging. While there were 18 days of skin pigment image data, one of these
days was also on day 26. As described in the methods, the histological images were
analyzed under a microscope using touplite software. In total, 1845 measurements were
taken of the epithelial layer. This process returned an average of ~230 measurements per
dose analyzed. An example of the image measurements can be seen in Image X.

59

Image 12: Epithelial Histology Measurements (Repeated)
Example of H&E Histology Measurements

Following the meticulous measurement process, all measurements for each dose
were averaged, and the standard deviations were calculated. The averaged data is
represented in Figure X below.
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Figure 15: H&E Histology Epithelial Thickness
Epithelial thickness data measured and analyzed via an H&E
histology stain. Each bar represents a different mode and dose
combination (FLASH/CONV of 0/20/30/40 Gy) from 26 days after
irradiation.
As is clear from the data, two trends are readily apparent from the H&E
histology-based epithelial thickness data. Firstly, an epithelial thinning proportional dose
trend holds within each mode of radiotherapy. For both FLASH and CONV RT, 40 Gy
resulted in the most epithelial thinning, followed by 30 Gy, 20 Gy, and least of all the
control. This trend was expected given that increasing radiotherapeutic dose is wellknown to result in epithelial thinning. The second and more critical trend gleaned from
this H&E histology data set was that FLASH RT elicited a more severe thinning reaction
across overall doses than the CONV dose rate and, thus, resulted in more radiotherapy-
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induced damage. FLASH 20, 30, and 40 Gy doses resulted in epithelial layers 3.5%,
1.7%, and 10.1% less thick than CONV RT of the same doses.

Limitations
The actual H&E staining technique is unlikely to serve as any source of error for
this data analysis due to the refined and regularly practiced techniques implemented
within Dartmouth-Hitchcock pathology labs. Still, the epithelial measurement process
under the microscope could have allowed some room for error. Most notably, the
researcher who performed all 1845 measurements, while knowledgeable enough to write
this thesis, is not a trained pathologist. Thus, identifying the epithelial endpoints on either
side of the epithelial layer had, albeit small, room for error.

OCT Imaging

Results
The final data set considered in this multi-data type experiment was the OCT
imaging data, taken on day 26 after irradiation, as described in the methods. Images were
taken of every region of interest and analyzed for changes in epithelial thickness.
Generally, two trends were seen amidst this OCT data set. First, epithelial thinning was
proportional to dose for both FLASH and CONV modes. Ultimately, higher doses
resulted in more thinning. Second, in line with the H&E histology data, FLASH elicited a
more robust epithelial thinning response than conventional RT. Both of these trends are
seen in Figure X.

62

Figure 16: OCT Epithelial Thickness
Bar plot of epithelial thickness data as visualized from the
OCT imagine data. All data was obtained 26 days after irradiation.
Limitations
The most significant limitation of the OCT imaging data is the stage of the
technique used to delineate between the beginning and endpoints of the epithelial layer. It
is promising that the two trends found from the H&E histology stains were also found in
the OCT imaging data. However, the actual micron thickness values of the epithelial
layer are not the same across the two data sets. The 0 Gy OCT averages are significantly
higher, while the 40 Gy OCT averages are considerably lower. Histology is the gold
standard of pathological tissue data acquisition. Thus, we only considered the histology
data for the rest of the data analysis on epithelial thickness. That said, with some
refinement, OCT imaging techniques are highly applicable to FLASH RT research. In the
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future, OCT might afford a necessary non-invasive yet functional data type for FLASH
pathological response research. That said, the technique likely needs to be refined, the
epithelial endpoints need to be more explicitly delineated. Thickness values ought to
correlate directly with histology data before the OCT values might be considered
independently.
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CONCLUSION

Co-Registry of Data
In summary, we collected four separate data sets from one comprehensive porcine
model study to explore the potentially damaging effects of FLASH RT on normal tissue.
Firstly, 144 standard RGB images were taken on an iPhone in order to assess for changes
in radiotherapy-induced skin pigmentation over time. Next, a skin biopsy was extracted
from the pig subject 26 days after irradiation, and two separate histology stains were
performed. The Masson-Fontana stain allowed for the visualization and assessment of
RT-induced epithelial melanin recruitment. The Hematoxylin & Eosin stain facilitated
the accurate measurement of epithelial thickness post-irradiation. In addition, OCT
images were taken on day 26 as well in order to measure the epithelial thickness. After
thorough analysis, each data set presented with two specific trends which explain what
happened to our pig's normal biological tissue after we irradiated it with FLASH
radiotherapy. Processing the skin pigmentation image data revealed that FLASH RT
elicited a significantly more potent response than CONV RT across every dose level.
Additionally, increasing the total dose resulted in increased skin darkening within both
FLASH and CONV RT. The second MATLAB application analysis then connected these
skin darkening trends with confirmed increases in epithelial melanin specifically. This
confirmation of melanin increase was essential to rule out other reasons behind the color
changes, such as but not limited to poor perfusion. Thus, we confirmed that skin
darkening occurs because of increased recruitment of epithelial melanin in response to
radiation therapy. The third link in the chain comes from the H&E histology data, which
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correlated skin darkening - and thus increased epithelial melanin - with decreased
epithelial thickness. The same can be said of the OCT imaging data, which assessed
epithelial thickness and returned the same trends. However, the OCT data did not line up
with actual thickness values returned by the histology analysis, which indicates that the
OCT imaging technique - while very promising - needs to be slightly refined.
Regardless, the same trends were found in the epithelial thickness data as the
melanin and pigment data. As total dose increases in either FLASH or CONV modalities,
skin darkness and epithelial melanin increase while epithelial thickness decreases. More
telling: FLASH RT produced darker skin pigmentation, higher concentrations of
epithelial melanin, and a significantly thinner epithelial layer. Epithelial thinning is well
documented in the literature as evidence of radiation-induced damage. Thus, the data of
this one study contradicts both our hypothesis and the overall trend we see in FLASH
literature. The FLASH effect as it is traditionally defined was not evident in the results. If
this experiment corroborated the FLASH effect, FLASH RT doses would have resulted in
lighter skin darkening, lower melanin concentrations, less epithelial thinning, and
increased normal tissue sparing than equivalent conventional doses. However, these
expected trends did not present themselves. The visible results, not considering any tests
for statistical significance, from this pig study indicate that FLASH RT, as opposed to
CONV RT, ultimately elicited more radiotherapy-induced damage to the normal tissue
under observation. These trends, consistent across all three data sets, are visualized in
Figure X.
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Figure 17: Trends in the Co-Registry of Data
Co-registry of three FLASH data sets 26 days after
irradiation. Red lines show average epidermal thickness, black
lines show skin pigmentation ratios, and green lines show epithelial
melanin concentrations. Solid lines represent FLASH data while
dashed lines represent CONV data.
The trends in these three data sets are very visually apparent. But are these
differences statistically significant? Further statistical analysis suggests that the evidence
may be somewhat more convoluted. Consider Table X below.

67

Table 2: P Values
Every P value between FLASH and CONV modes of every
dose level for the skin pigment, percent epithelial melanin, and
epithelial thickness data. Orange highlighted rectangles are outside
the designated 0.01 threshold. Green highlighted rectangles
indicate statistically significant p values (less than or equal to 0.01)
where FLASH and CONV modes returns significantly different
results.
A one-tailed t-test was performed between FLASH and CONV modes for all three
data sets. Considering the p values for the RGB image skin pigment data, it is clear that
FLASH resulted in statistically significant differences. For all three testing levels - 20,
30, and 40 Gy - FLASH provokes a significantly more severe response regarding visible
skin darkening. The percent epithelial melanin data tells nearly the same story except for
the 40 Gy p-value, which lands somewhat outside the statistically significant range.
While not reaching the 0.01 p-value threshold (p = 0.089), the percent epithelial melanin
from the FLASH 40 Gy still returned 21.5% higher than the conventional RT biopsy of
the same dose. Thus, the difference is visually and conceptually notable even if it may
not exhibit calculated statistical significance. The most significant insight provided by the
p-values calculated between FLASH and CONV modes comes in the epithelial thickness
measurements. Only FLASH 40 Gy presented with a statistically significant difference (p
= 0.004). Thus, we find a statistical presentation of insignificance despite the visual and
conceptual epithelial thinning we can readily see with our eyes. This likely means that the
traditional FLASH effect - characterized by improved normal tissue sparing - was not
achieved in this study. There is, of course, a possibility that the normal tissue damage
elicited by FLASH was not significantly more severe than CONV. Perhaps the normal
tissue damage incurred from FLASH RT was merely comparable to the CONV-induced
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damage. Thus, our data may still be good news for the future and potential of FLASH RT
research because equivalent normal tissue damage could still warrant the use of FLASH
if other benefits outside the therapeutic ratio held. Most notably, the shortened total
duration of treatment could serve as a case for the future of FLASH radiotherapy alone.

Skin Pigmentation as a Non-Invasive Indicator for Epithelial Thinning
Regardless of whether or not the RT-induced epithelial thinning was statistically
significant, we determined that skin pigmentation changes are a fantastic indicator of
epithelial thinning. A correlation test showed that at 26 days after irradiation, there was a
-0.91 linear correlation between increased CONV RT-induced changes in the darkness of
skin pigment and the thinning of the epithelial layer. Further, according to the R-Squared
values, the changes in the pigmentation ratio accounts for 82% of the changes in
epithelial thickness for CONV RT. For FLASH, the correlation was even stronger at 0.99 linear correlation. The FLASH R Squared value suggested that changes in the
pigmentation ratio accounted for 99% of the changes in epithelial thickness. The
statistically significant correlation values warranted creating a model for considering skin
pigmentation as a non-invasive indicator for radiation-induced epithelial thinning
damage. Due to the restrictions of our animal use protocol, our epithelial thickness data is
admittedly limited to only the 26th day after irradiation. More values across the time of
post-irradiation reaction are needed to develop a comprehensive and accurate model to
replace the need for biopsy in this type of data analysis. Using only the day 26 data,
however, a crude model is viable and was created. The skin pigmentation to epithelial
thinning equations are presented as Equations X and X.
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Equations 3+4: Linear Regression Models for CONV + FLASH
Linear regression equations between Skin Pigmentation
Ratio (SPR) and ET (Epithelial Thickness in microns) for FLASH
and CONV RT.

These equations suggest how much epithelial thinning is occurring as a result of
FLASH and CONV radiation therapy. According to the above analysis, a 0.1 increase in
the skin pigmentation ratio results in a ~24 and ~62-micron decrease in epithelial
thickness for FLASH and CONV, respectively. Why the same change in skin
pigmentation ratio results in a threefold more severe epithelial thinning in CONV RT is
unclear. This disparity in slope is most likely due to, as noted, the crudeness of this
preliminary model based on only one day. In the future, the same model should be
created considering many post-irradiation days of data from multiple studies. Regardless,
this linear model could provide an extremely viable stand-in for invasive biopsy when
assessing radiation-induced damage to normal tissue. If FLASH RT transitions into the
clinical trial setting with human patients, which is likely soon to occur, a mass-scale
biopsy will be less and less feasible. A non-invasive stand-in for evaluating the FLASH
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effect may prove essential. Correlating skin pigmentation to epithelial thinning as a
metric for RT-induced damage could prove to be the ticket as investigated here for the
first time in the literature.

A Case for FLASH: Sociomedical Implications
The field of radiation oncology still faces tremendous barriers to providing
optimal patient therapy. Radiotherapy for brain tumors has been shown to hinder
neurocognitive functioning in juveniles [38]. In the same vein, conventional radiotherapy
patients often incur significant damage to healthy tissue surrounding the targeted tumor.
For example, in patients with cutaneous tumors, conventional RT can leave permanent
and visible damage to healthy tissue surrounding the targeted mass [29]. Furthermore,
one of the most common side effects of conventional RT is treatment-related fatigue
reported in 80% of patients during treatment and 30% during follow-up visits [39].
Among other medically problematic side effects, these concerning issues drive a need for
the continual widening of the achievable therapeutic ratio. Unfortunately, the results of
this study are not the strongest advocate for the FLASH effect. That said, there are other
factors in radiotherapeutic treatment that can be tweaked to provide better comprehensive
care. Forgive the speculative nature of the claims to come, but they might be important
topics to consider now, in the early stages of FLASH RT research. Systemic health care
disparities are plaguing modern-day radiotherapy treatment. In Canada, for example,
where cancer is the leading cause of death and premature mortality, regional disparities in
cancer outcomes are rampant. These disparities are, in part, due to the unequal
geographical distribution of radiotherapy treatment [6 - Chan - pg. 52]. For Canada, a

71

“high-income” country with universal health care, the problem with inequitable
radiotherapy accessibility has less to do with radiotherapy capacity and much more to do
with Canada’s large geographic area and small population density. In other words, large
distances and long travel times to radiation treatment centers serve as barriers to care for
some more than others. In the most extreme case, inhabitants of Nunavut in 2012 had to
travel over 2000 kilometers for treatment at the nearest radiotherapy center. Geographical
barriers in Canadian clinical RT have led to disparities in mortality-to-incidence rates in
the country [40]. The disparities are better understood considering a typical radiotherapy
treatment plan is executed for 10-30 minutes every day, for five days a week, over
several weeks [8]. The typical treatment time frame compounds the issue of distance and
travel. Imagine the case of the rural farmer who is in dire need of fractionated
radiotherapy but lives two hours away from the nearest radiotherapy clinic. How likely
will he be able to commit to a four hours round trip five days of the week for a month and
a half? Chances could be slim to none. It is in this situation where FLASH RT could
make a significant difference. Even with only equivalent normal tissue damage to CONV,
the shortened duration of FLASH treatment could mean a more accessible treatment plan.
Much more research ought to be conducted to determine just how much of a time
difference this new technique might enforce. Even if the increased dose rate allowed for
hypofractionated doses to be administered in half the number of appointments, the
change in access for geographically distant patients could be exponential.
Factors beyond geographical barriers also play into the global crisis of inequitable
access to radiotherapy. Evidence suggests that disparities in radiotherapy treatment are
also tied to socioeconomic trends. A study in Europe showed that low, first-quartile,
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income patients were only 76% as likely to receive preoperative radiotherapy in rectal
cancer compared to patients with high income in the fourth quartile [41]. Cutting down
the number of RT appointments and total treatment duration via FLASH RT may prove
to be essential to breaking down inequitable barriers to RT access in the decades to
come.

Future Research
Of course, for any of these postulations to be realized, significantly more progress
must be made in the field of FLASH RT. This study does not present any obvious
evidence to corroborate the FLASH effect, even though it has been increasingly
documented in the literature. Our findings may even suggest the opposite: that FLASH
RT shows evidence of causing more severe radiation-induced damage than CONV RT in
the form of epithelial thinning. That said, it is critical to consider that this is only one
study on one pig. Moreover, this study was our lab's first attempt to orchestrate a porcine
model for investigating the FLASH effect. Limitations have already been addressed for
each data set, but there are sure to be other areas in need of tightening to obtain the best
and most accurate results. More statistical tests ought to be run on the data. Possibly, a
one-tailed t-test was not warranted for this data co-registry. Perhaps an ANOVA test
would have served better. As of May 2021, a second pig study is currently underway to
further investigate the FLASH effect on normal pig tissue. Both applications developed
for the analysis in this thesis project will continue to be used to assess epithelial melanin
concentrations and radiation-induced changes in skin pigmentation. This study did not
corroborate the FLASH effect, but it was merely one study. The majority of
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contemporary literature strongly suggests otherwise, and more research is required to
accurately define both the parameters and effects of FLASH ultra-high dose rate
radiotherapy.
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REFERENCES:
Appendices
Skin Pigmentation Quantification App Code
classdef FLASHPigApp3 < matlab.apps.AppBase
% Properties that correspond to app components
properties (Access = public)
UIFigure
matlab.ui.Figure
TabGroup
matlab.ui.container.TabGroup
ImageEvaluationTab
matlab.ui.container.Tab
UploadImageButton
matlab.ui.control.Button
SpecifyDateDatePickerLabel
matlab.ui.control.Label
SpecifyDateDatePicker
matlab.ui.control.DatePicker
SpecifyDataTypeDropDownLabel matlab.ui.control.Label
SpecifyDataTypeDropDown
matlab.ui.control.DropDown
AnalyzePixelsButton
matlab.ui.control.Button
UITable
matlab.ui.control.Table
UIAxes
matlab.ui.control.UIAxes
SelectxlsxButton
matlab.ui.control.Button
TextArea_2
matlab.ui.control.TextArea
end
properties (Access = private)
t % Table to share between callbacks
fullpathname % excel sheet to share between callbacks
end
methods (Access = private)
% Button pushed function: UploadImageButton
function UploadImageButtonPushed(app, event)
global imageImport;
[filename, pathname] = uigetfile({'*.png'}, "Open
file");
fullpathname = strcat(pathname, filename);
imageImport = imread(fullpathname);
imshow(imageImport, 'parent', app.UIAxes);
end
% Button pushed function: AnalyzePixelsButton
function AnalyzePixelsButtonPushed(app, event)
global imageImport;
aImage = imageImport; %import image
%% Select Pixel Regions; 5 Reference then 5 Test
IRef1 = imcrop(aImage);
IRef2 = imcrop(aImage);
IRef3 = imcrop(aImage);
IRef4 = imcrop(aImage);
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IRef5 = imcrop(aImage);
IRef6 = imcrop(aImage);
IRef7 = imcrop(aImage);
IRef8 = imcrop(aImage);
IRef9 = imcrop(aImage);
IRef10 = imcrop(aImage);
ITest1 = imcrop(aImage);
ITest2 = imcrop(aImage);
ITest3 = imcrop(aImage);
ITest4 = imcrop(aImage);
ITest5 = imcrop(aImage);
ITest6 = imcrop(aImage);
ITest7 = imcrop(aImage);
ITest8 = imcrop(aImage);
ITest9 = imcrop(aImage);
ITest10 = imcrop(aImage);
%% RED
%extract matrix data from reference crops
valuesRedRef1 = IRef1(:,:,1);
valuesRedRef2 = IRef2(:,:,1);
valuesRedRef3 = IRef3(:,:,1);
valuesRedRef4 = IRef4(:,:,1);
valuesRedRef5 = IRef5(:,:,1);
valuesRedRef6 = IRef6(:,:,1);
valuesRedRef7 = IRef7(:,:,1);
valuesRedRef8 = IRef8(:,:,1);
valuesRedRef9 = IRef9(:,:,1);
valuesRedRef10 = IRef10(:,:,1);
%extract matrix data from test crops
valuesRedTest1 = ITest1(:,:,1);
valuesRedTest2 = ITest2(:,:,1);
valuesRedTest3 = ITest3(:,:,1);
valuesRedTest4 = ITest4(:,:,1);
valuesRedTest5 = ITest5(:,:,1);
valuesRedTest6 = ITest6(:,:,1);
valuesRedTest7 = ITest7(:,:,1);
valuesRedTest8 = ITest8(:,:,1);
valuesRedTest9 = ITest9(:,:,1);
valuesRedTest10 = ITest10(:,:,1);
%calculate mean value of reference crops
meanRedRef1 = mean(valuesRedRef1(:));
meanRedRef2 = mean(valuesRedRef2(:));
meanRedRef3 = mean(valuesRedRef3(:));
meanRedRef4 = mean(valuesRedRef4(:));
meanRedRef5 = mean(valuesRedRef5(:));
meanRedRef6 = mean(valuesRedRef6(:));
meanRedRef7 = mean(valuesRedRef7(:));
meanRedRef8 = mean(valuesRedRef8(:));
meanRedRef9 = mean(valuesRedRef9(:));
meanRedRef10 = mean(valuesRedRef10(:));
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RedReferences =
[meanRedRef1,meanRedRef2,meanRedRef3,meanRedRef4,meanRedRef5...
meanRedRef6,meanRedRef7,meanRedRef8,meanRedRef9,meanRedRef10];
%calculate mean value of test crops
meanRedTest1 = mean(valuesRedTest1(:));
meanRedTest2 = mean(valuesRedTest2(:));
meanRedTest3 = mean(valuesRedTest3(:));
meanRedTest4 = mean(valuesRedTest4(:));
meanRedTest5 = mean(valuesRedTest5(:));
meanRedTest6 = mean(valuesRedTest6(:));
meanRedTest7 = mean(valuesRedTest7(:));
meanRedTest8 = mean(valuesRedTest8(:));
meanRedTest9 = mean(valuesRedTest9(:));
meanRedTest10 = mean(valuesRedTest10(:));
RedTests =
[meanRedTest1,meanRedTest2,meanRedTest3,meanRedTest4,meanRedTest5...
meanRedTest6,meanRedTest7,meanRedTest8,meanRedTest9,meanRedTest10];
ratioIndex = 1;
RedRatios = zeros(1,100);
for testIndex = RedTests
for referenceIndex = RedReferences
contrast = (testIndex referenceIndex)/referenceIndex;
RedRatios(ratioIndex) = contrast;
ratioIndex = ratioIndex + 1;
end
end
%Standard Deviation Ratio
stdRedRatios = std(RedRatios);
%Average Ratio Value
avgRedRatios = mean(RedRatios);
%% GREEN
%extract matrix data from reference crops
valuesGreenRef1 = IRef1(:,:,2);
valuesGreenRef2 = IRef2(:,:,2);
valuesGreenRef3 = IRef3(:,:,2);
valuesGreenRef4 = IRef4(:,:,2);
valuesGreenRef5 = IRef5(:,:,2);
valuesGreenRef6 = IRef6(:,:,2);
valuesGreenRef7 = IRef7(:,:,2);
valuesGreenRef8 = IRef8(:,:,2);
valuesGreenRef9 = IRef9(:,:,2);
valuesGreenRef10 = IRef10(:,:,2);
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%extract matrix data from test crops
valuesGreenTest1 = ITest1(:,:,2);
valuesGreenTest2 = ITest2(:,:,2);
valuesGreenTest3 = ITest3(:,:,2);
valuesGreenTest4 = ITest4(:,:,2);
valuesGreenTest5 = ITest5(:,:,2);
valuesGreenTest6 = ITest6(:,:,2);
valuesGreenTest7 = ITest7(:,:,2);
valuesGreenTest8 = ITest8(:,:,2);
valuesGreenTest9 = ITest9(:,:,2);
valuesGreenTest10 = ITest10(:,:,2);
%calculate mean value of reference crops
meanGreenRef1 = mean(valuesGreenRef1(:));
meanGreenRef2 = mean(valuesGreenRef2(:));
meanGreenRef3 = mean(valuesGreenRef3(:));
meanGreenRef4 = mean(valuesGreenRef4(:));
meanGreenRef5 = mean(valuesGreenRef5(:));
meanGreenRef6 = mean(valuesGreenRef6(:));
meanGreenRef7 = mean(valuesGreenRef7(:));
meanGreenRef8 = mean(valuesGreenRef8(:));
meanGreenRef9 = mean(valuesGreenRef9(:));
meanGreenRef10 = mean(valuesGreenRef10(:));
GreenReferences =
[meanGreenRef1,meanGreenRef2,meanGreenRef3,meanGreenRef4,meanGreenRe
f5...
meanGreenRef6,meanGreenRef7,meanGreenRef8,meanGreenRef9,meanGreenRef
10];
%calculate mean value of test crops
meanGreenTest1 = mean(valuesGreenTest1(:));
meanGreenTest2 = mean(valuesGreenTest2(:));
meanGreenTest3 = mean(valuesGreenTest3(:));
meanGreenTest4 = mean(valuesGreenTest4(:));
meanGreenTest5 = mean(valuesGreenTest5(:));
meanGreenTest6 = mean(valuesGreenTest6(:));
meanGreenTest7 = mean(valuesGreenTest7(:));
meanGreenTest8 = mean(valuesGreenTest8(:));
meanGreenTest9 = mean(valuesGreenTest9(:));
meanGreenTest10 = mean(valuesGreenTest10(:));
GreenTests =
[meanGreenTest1,meanGreenTest2,meanGreenTest3,meanGreenTest4,meanGre
enTest5...
meanGreenTest6,meanGreenTest7,meanGreenTest8,meanGreenTest9,meanGree
nTest10];
ratioIndex = 1;
GreenRatios = zeros(1,100);
for testIndex = GreenTests
for referenceIndex = GreenReferences
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contrast = (testIndex referenceIndex)/referenceIndex;
GreenRatios(ratioIndex) = contrast;
ratioIndex = ratioIndex + 1;
end
end
%Standard Deviation Ratio
stdGreenRatios = std(GreenRatios);
%Average Ratio Value
avgGreenRatios = mean(GreenRatios);
%% BLUE
%extract matrix data from reference crops
valuesBlueRef1 = IRef1(:,:,3);
valuesBlueRef2 = IRef2(:,:,3);
valuesBlueRef3 = IRef3(:,:,3);
valuesBlueRef4 = IRef4(:,:,3);
valuesBlueRef5 = IRef5(:,:,3);
valuesBlueRef6 = IRef6(:,:,3);
valuesBlueRef7 = IRef7(:,:,3);
valuesBlueRef8 = IRef8(:,:,3);
valuesBlueRef9 = IRef9(:,:,3);
valuesBlueRef10 = IRef10(:,:,3);
%extract matrix data from test crops
valuesBlueTest1 = ITest1(:,:,3);
valuesBlueTest2 = ITest2(:,:,3);
valuesBlueTest3 = ITest3(:,:,3);
valuesBlueTest4 = ITest4(:,:,3);
valuesBlueTest5 = ITest5(:,:,3);
valuesBlueTest6 = ITest6(:,:,3);
valuesBlueTest7 = ITest7(:,:,3);
valuesBlueTest8 = ITest8(:,:,3);
valuesBlueTest9 = ITest9(:,:,3);
valuesBlueTest10 = ITest10(:,:,3);
%calculate mean value of reference crops
meanBlueRef1 = mean(valuesBlueRef1(:));
meanBlueRef2 = mean(valuesBlueRef2(:));
meanBlueRef3 = mean(valuesBlueRef3(:));
meanBlueRef4 = mean(valuesBlueRef4(:));
meanBlueRef5 = mean(valuesBlueRef5(:));
meanBlueRef6 = mean(valuesBlueRef6(:));
meanBlueRef7 = mean(valuesBlueRef7(:));
meanBlueRef8 = mean(valuesBlueRef8(:));
meanBlueRef9 = mean(valuesBlueRef9(:));
meanBlueRef10 = mean(valuesBlueRef10(:));
BlueReferences =
[meanBlueRef1,meanBlueRef2,meanBlueRef3,meanBlueRef4,meanBlueRef5...
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meanBlueRef6,meanBlueRef7,meanBlueRef8,meanBlueRef9,meanBlueRef10];
%calculate mean value of test crops
meanBlueTest1 = mean(valuesBlueTest1(:));
meanBlueTest2 = mean(valuesBlueTest2(:));
meanBlueTest3 = mean(valuesBlueTest3(:));
meanBlueTest4 = mean(valuesBlueTest4(:));
meanBlueTest5 = mean(valuesBlueTest5(:));
meanBlueTest6 = mean(valuesBlueTest6(:));
meanBlueTest7 = mean(valuesBlueTest7(:));
meanBlueTest8 = mean(valuesBlueTest8(:));
meanBlueTest9 = mean(valuesBlueTest9(:));
meanBlueTest10 = mean(valuesBlueTest10(:));
BlueTests =
[meanBlueTest1,meanBlueTest2,meanBlueTest3,meanBlueTest4,meanBlueTes
t5...
meanBlueTest6,meanBlueTest7,meanBlueTest8,meanBlueTest9,meanBlueTest
10];
ratioIndex = 1;
BlueRatios = zeros(1,100);
for testIndex = BlueTests
for referenceIndex = BlueReferences
contrast = (testIndex referenceIndex)/referenceIndex;
BlueRatios(ratioIndex) = contrast;
ratioIndex = ratioIndex + 1;
end
end
%Standard Deviation Ratio
stdBlueRatios = std(BlueRatios);
%Average Ratio Value
avgBlueRatios = mean(BlueRatios);
%% GRAYSCALE
gRef1 = rgb2gray(IRef1);
gRef2 = rgb2gray(IRef2);
gRef3 = rgb2gray(IRef3);
gRef4 = rgb2gray(IRef4);
gRef5 = rgb2gray(IRef5);
gRef6 = rgb2gray(IRef6);
gRef7 = rgb2gray(IRef7);
gRef8 = rgb2gray(IRef8);
gRef9 = rgb2gray(IRef9);
gRef10 = rgb2gray(IRef10);
gTest1 = rgb2gray(ITest1);
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gTest2 = rgb2gray(ITest2);
gTest3 = rgb2gray(ITest3);
gTest4 = rgb2gray(ITest4);
gTest5 = rgb2gray(ITest5);
gTest6 = rgb2gray(ITest6);
gTest7 = rgb2gray(ITest7);
gTest8 = rgb2gray(ITest8);
gTest9 = rgb2gray(ITest9);
gTest10 = rgb2gray(ITest10);
%calculate mean value of reference crops
meanGrayRef1 = mean(gRef1(:));
meanGrayRef2 = mean(gRef2(:));
meanGrayRef3 = mean(gRef3(:));
meanGrayRef4 = mean(gRef4(:));
meanGrayRef5 = mean(gRef5(:));
meanGrayRef6 = mean(gRef6(:));
meanGrayRef7 = mean(gRef7(:));
meanGrayRef8 = mean(gRef8(:));
meanGrayRef9 = mean(gRef9(:));
meanGrayRef10 = mean(gRef10(:));
%calculate mean value of test crops
meanGrayTest1 = mean(gTest1(:));
meanGrayTest2 = mean(gTest2(:));
meanGrayTest3 = mean(gTest3(:));
meanGrayTest4 = mean(gTest4(:));
meanGrayTest5 = mean(gTest5(:));
meanGrayTest6 = mean(gTest6(:));
meanGrayTest7 = mean(gTest7(:));
meanGrayTest8 = mean(gTest8(:));
meanGrayTest9 = mean(gTest9(:));
meanGrayTest10 = mean(gTest10(:));
GrayReferences =
[meanGrayRef1,meanGrayRef2,meanGrayRef3,meanGrayRef4,meanGrayRef5...
meanGrayRef6,meanGrayRef7,meanGrayRef8,meanGrayRef9,meanGrayRef10];
GrayTests =
[meanGrayTest1,meanGrayTest2,meanGrayTest3,meanGrayTest4,meanGrayTes
t5...
meanGrayTest6,meanGrayTest7,meanGrayTest8,meanGrayTest9,meanGrayTest
10];
ratioIndex = 1;
GrayRatios = zeros(1,100);
for testIndex = GrayTests
for referenceIndex = GrayReferences
contrast = (testIndex referenceIndex)/referenceIndex;
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GrayRatios(ratioIndex) = contrast;
ratioIndex = ratioIndex + 1;
end
end
%Standard Deviation Ratio
stdGrayRatios = std(GrayRatios);
%Average Ratio Value
avgGrayRatios = mean(GrayRatios);
%Obtain and create new data table row values
d = datestr(app.SpecifyDateDatePicker.Value);
dt = app.SpecifyDataTypeDropDown.Value;
nr = {d, dt, avgGrayRatios, stdGrayRatios, avgRedRatios,
stdRedRatios, ...
avgGreenRatios, stdGreenRatios, avgBlueRatios,
stdBlueRatios};
app.UITable.Data = [app.t;nr]; %new row added
app.t = app.UITable.Data;
writetable(app.t, app.fullpathname);
end
% Value changed function: SpecifyDateDatePicker
function SpecifyDateDatePickerValueChanged(app, event)
global date;
date = app.SpecifyDateDatePicker.Value;
end
% Value changed function: SpecifyDataTypeDropDown
function SpecifyDataTypeDropDownValueChanged(app, event)
global dataType;
dataType = app.SpecifyDataTypeDropDown.Value;
end
% Button pushed function: SelectxlsxButton
function SelectxlsxButtonPushed(app, event)
[filename, pathname] = uigetfile({'*.xlsx'}, "Open
file");
app.fullpathname = strcat(pathname, filename);
app.t = readtable(app.fullpathname);
app.UITable.Data = app.t;
app.t.Properties.VariableNames{1} = 'Date';
app.t.Properties.VariableNames{2} = 'Data_Type';
app.t.Properties.VariableNames{3} = 'Avg_Gray_Ratio';
app.t.Properties.VariableNames{4} = 'STD_Gray_Ratio';
app.t.Properties.VariableNames{5} = 'Avg_Red_Ratio';
app.t.Properties.VariableNames{6} = 'STD_Red_Ratio';
app.t.Properties.VariableNames{7} = 'Avg_Green_Ratio';
app.t.Properties.VariableNames{8} = 'STD_Green_Ratio';
app.t.Properties.VariableNames{9} = 'Avg_Blue_Ratio';
app.t.Properties.VariableNames{10} = 'STD_Blue_Ratio';
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app.UITable.ColumnName = app.t.Properties.VariableNames;
end
end
% App initialization and construction
methods (Access = private)
% Create UIFigure and components
function createComponents(app)
% Create UIFigure
app.UIFigure = uifigure;
app.UIFigure.Position = [100 100 756 588];
app.UIFigure.Name = 'UI Figure';
% Create TabGroup
app.TabGroup = uitabgroup(app.UIFigure);
app.TabGroup.Position = [1 1 756 588];
% Create ImageEvaluationTab
app.ImageEvaluationTab = uitab(app.TabGroup);
app.ImageEvaluationTab.Title = 'Image Evaluation';
% Create UploadImageButton
app.UploadImageButton = uibutton(app.ImageEvaluationTab,
'push');
app.UploadImageButton.ButtonPushedFcn =
createCallbackFcn(app, @UploadImageButtonPushed, true);
app.UploadImageButton.Position = [37 320 170 22];
app.UploadImageButton.Text = 'Upload Image';
% Create SpecifyDateDatePickerLabel
app.SpecifyDateDatePickerLabel =
uilabel(app.ImageEvaluationTab);
app.SpecifyDateDatePickerLabel.HorizontalAlignment =
'right';
app.SpecifyDateDatePickerLabel.Position = [37 286 74
22];
app.SpecifyDateDatePickerLabel.Text = 'Specify Date';
% Create SpecifyDateDatePicker
app.SpecifyDateDatePicker =
uidatepicker(app.ImageEvaluationTab);
app.SpecifyDateDatePicker.ValueChangedFcn =
createCallbackFcn(app, @SpecifyDateDatePickerValueChanged, true);
app.SpecifyDateDatePicker.Position = [126 286 81 22];
% Create SpecifyDataTypeDropDownLabel
app.SpecifyDataTypeDropDownLabel =
uilabel(app.ImageEvaluationTab);
app.SpecifyDataTypeDropDownLabel.HorizontalAlignment =
'right';
app.SpecifyDataTypeDropDownLabel.Position = [37 256 102
22];
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app.SpecifyDataTypeDropDownLabel.Text = 'Specify Data
Type';
% Create SpecifyDataTypeDropDown
app.SpecifyDataTypeDropDown =
uidropdown(app.ImageEvaluationTab);
app.SpecifyDataTypeDropDown.Items = {'CONV Control',
'CONV 20 Gy', 'CONV 30 Gy', 'CONV 40 Gy', 'FLASH Control', 'FLASH 20
Gy', 'FLASH 30 Gy', 'FLASH 40 Gy'};
app.SpecifyDataTypeDropDown.ValueChangedFcn =
createCallbackFcn(app, @SpecifyDataTypeDropDownValueChanged, true);
app.SpecifyDataTypeDropDown.Position = [154 256 53 22];
app.SpecifyDataTypeDropDown.Value = 'CONV Control';
% Create AnalyzePixelsButton
app.AnalyzePixelsButton =
uibutton(app.ImageEvaluationTab, 'push');
app.AnalyzePixelsButton.ButtonPushedFcn =
createCallbackFcn(app, @AnalyzePixelsButtonPushed, true);
app.AnalyzePixelsButton.Position = [37 223 170 22];
app.AnalyzePixelsButton.Text = 'Analyze Pixels';
% Create UITable
app.UITable = uitable(app.ImageEvaluationTab);
app.UITable.ColumnName = {'Date'; 'Data_Type';
'avgGrayRatios'; 'stdGRayRatios'; 'avgRedRatios'; 'stdRedRatios';
'avgGreenRatios'; 'stdGreenRatios'; 'avgBlueRatios';
'stdBlueRatios'};
app.UITable.RowName = {''; ''};
app.UITable.Position = [246 33 498 510];
% Create UIAxes
app.UIAxes = uiaxes(app.ImageEvaluationTab);
title(app.UIAxes, 'Selected Image')
xlabel(app.UIAxes, '')
ylabel(app.UIAxes, '')
app.UIAxes.PlotBoxAspectRatio = [1 0.854291417165669
0.854291417165669];
app.UIAxes.Position = [23 379 197 164];
% Create SelectxlsxButton
app.SelectxlsxButton = uibutton(app.ImageEvaluationTab,
'push');
app.SelectxlsxButton.ButtonPushedFcn =
createCallbackFcn(app, @SelectxlsxButtonPushed, true);
app.SelectxlsxButton.Position = [37 358 170 22];
app.SelectxlsxButton.Text = 'Select.xlsx';
% Create TextArea_2
app.TextArea_2 = uitextarea(app.ImageEvaluationTab);
app.TextArea_2.Position = [13 33 217 176];
app.TextArea_2.Value = {'Instructions:'; '1 ) Select new
.xlsx file pre-set with columns names in cells 1a-r'; '2) Upload
given image for analysis'; '3 ) Specify Date'; '4) Indicate Testing
Group'; '5) Press Analyze Button'; '6) Draw 3 reference squares
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surrounding testing area; double click'; '7) Draw 1 test square;
double click'; '8) Data will automatically be uploaded to excel
file'};
end
end
methods (Access = public)
% Construct app
function app = FLASHPigApp3
% Create and configure components
createComponents(app)
% Register the app with App Designer
registerApp(app, app.UIFigure)
if nargout == 0
clear app
end
end
% Code that executes before app deletion
function delete(app)
% Delete UIFigure when app is deleted
delete(app.UIFigure)
end
end
end

Epithelial Melanin Quantification App Code
classdef MelaninPigApp < matlab.apps.AppBase
% Properties that correspond to app components
properties (Access = public)
UIFigure
matlab.ui.Figure
TabGroup
matlab.ui.container.TabGroup
ImageEvaluationTab
matlab.ui.container.Tab
UploadImageButton
matlab.ui.control.Button
SpecifyDateDatePickerLabel
matlab.ui.control.Label
SpecifyDateDatePicker
matlab.ui.control.DatePicker
SpecifyDataTypeDropDownLabel matlab.ui.control.Label
SpecifyDataTypeDropDown
matlab.ui.control.DropDown
AnalyzePercentMelaninButton
matlab.ui.control.Button
UITable
matlab.ui.control.Table
UIAxes
matlab.ui.control.UIAxes
SelectxlsxButton
matlab.ui.control.Button
TextArea_2
matlab.ui.control.TextArea
end
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properties (Access = private)
t % Table to share between callbacks
fullpathname % excel sheet to share between callbacks
end
methods (Access = private)
% Button pushed function: UploadImageButton
function UploadImageButtonPushed(app, event)
global imageImport;
[filename, pathname] = uigetfile({'*.jpg'}, "Open
file");
fullpathname = strcat(pathname, filename);
imageImport = imread(fullpathname);
imshow(imageImport, 'parent', app.UIAxes);
end
% Button pushed function: AnalyzePercentMelaninButton
function AnalyzePercentMelaninButtonPushed(app, event)
global imageImport;
I = imageImport; %import image
% Enhance Image via linear contrast stretch
stretched_I = imadjust(I, stretchlim(I));
%figure
%imshow(stretched_I);
%title('Melanin Histology After Contrast Stretch');
% Convert Stretched to Binary Image
level = 0.1;
gray_stretched_I = rgb2gray(stretched_I);
binary_stretched_I = imbinarize(gray_stretched_I,
level);
%imshowpair(stretched_I, binary_stretched_I, 'montage');
% Part 8: Identify Epidermal Layer via Freehand ROI
hFigure = figure();
hAxes = axes('Parent', hFigure);
hImage1 = imshow(binary_stretched_I, 'Parent', hAxes);
drawnow; % Ensure the image gets drawn.
hold on;
hImage2 = imshow(stretched_I, 'Parent', hAxes);
hold off;
hFreehand = drawfreehand;
hImages = findobj(hFreehand.Parent,'Type','image');
mask = hFreehand.createMask(hImages(1).CData);
set(hImages(1),'AlphaData', ~mask);
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% Analyze for Melanin Ratio
pixelsInsideMask = binary_stretched_I(mask);
numTotalPixels
numWhitePixels
number of non-zero pixels
numBlackPixels
percentMelanin

= length(pixelsInsideMask);
= nnz(pixelsInsideMask); % Count of
= numTotalPixels - numWhitePixels;
= numBlackPixels/numTotalPixels;

%Obtain and create new data table row values
d = datestr(app.SpecifyDateDatePicker.Value);
dt = app.SpecifyDataTypeDropDown.Value;
nr = {d, dt, percentMelanin, numTotalPixels,
numWhitePixels, numBlackPixels};
app.UITable.Data = [app.t;nr]; %new row added
app.t = app.UITable.Data;
writetable(app.t, app.fullpathname);
end
% Value changed function: SpecifyDateDatePicker
function SpecifyDateDatePickerValueChanged(app, event)
global date;
date = app.SpecifyDateDatePicker.Value;
end
% Value changed function: SpecifyDataTypeDropDown
function SpecifyDataTypeDropDownValueChanged(app, event)
global dataType;
dataType = app.SpecifyDataTypeDropDown.Value;
end
% Button pushed function: SelectxlsxButton
function SelectxlsxButtonPushed(app, event)
[filename, pathname] = uigetfile({'*.xlsx'}, "Open
file");
app.fullpathname = strcat(pathname, filename);
app.t = readtable(app.fullpathname);
app.UITable.Data = app.t;
app.t.Properties.VariableNames{1} = 'Date';
app.t.Properties.VariableNames{2} = 'Data_Type';
app.t.Properties.VariableNames{3} = 'Percent_Melanin';
app.t.Properties.VariableNames{4} = 'Total_Pixels';
app.t.Properties.VariableNames{5} = 'White_Pixels';
app.t.Properties.VariableNames{6} = 'Black_Pixels';
app.UITable.ColumnName = app.t.Properties.VariableNames;
end
end
% App initialization and construction
methods (Access = private)
% Create UIFigure and components
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function createComponents(app)
% Create UIFigure
app.UIFigure = uifigure;
app.UIFigure.Position = [100 100 756 588];
app.UIFigure.Name = 'UI Figure';
% Create TabGroup
app.TabGroup = uitabgroup(app.UIFigure);
app.TabGroup.Position = [1 1 756 588];
% Create ImageEvaluationTab
app.ImageEvaluationTab = uitab(app.TabGroup);
app.ImageEvaluationTab.Title = 'Image Evaluation';
% Create UploadImageButton
app.UploadImageButton = uibutton(app.ImageEvaluationTab,
'push');
app.UploadImageButton.ButtonPushedFcn =
createCallbackFcn(app, @UploadImageButtonPushed, true);
app.UploadImageButton.Position = [37 320 170 22];
app.UploadImageButton.Text = 'Upload Image';
% Create SpecifyDateDatePickerLabel
app.SpecifyDateDatePickerLabel =
uilabel(app.ImageEvaluationTab);
app.SpecifyDateDatePickerLabel.HorizontalAlignment =
'right';
app.SpecifyDateDatePickerLabel.Position = [37 286 74
22];
app.SpecifyDateDatePickerLabel.Text = 'Specify Date';
% Create SpecifyDateDatePicker
app.SpecifyDateDatePicker =
uidatepicker(app.ImageEvaluationTab);
app.SpecifyDateDatePicker.ValueChangedFcn =
createCallbackFcn(app, @SpecifyDateDatePickerValueChanged, true);
app.SpecifyDateDatePicker.Position = [126 286 81 22];
% Create SpecifyDataTypeDropDownLabel
app.SpecifyDataTypeDropDownLabel =
uilabel(app.ImageEvaluationTab);
app.SpecifyDataTypeDropDownLabel.HorizontalAlignment =
'right';
app.SpecifyDataTypeDropDownLabel.Position = [37 256 102
22];
app.SpecifyDataTypeDropDownLabel.Text = 'Specify Data
Type';
% Create SpecifyDataTypeDropDown
app.SpecifyDataTypeDropDown =
uidropdown(app.ImageEvaluationTab);
app.SpecifyDataTypeDropDown.Items = {'CONV Control',
'CONV 20 Gy', 'CONV 30 Gy', 'CONV 40 Gy', 'FLASH Control', 'FLASH 20
Gy', 'FLASH 30 Gy', 'FLASH 40 Gy'};
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app.SpecifyDataTypeDropDown.ValueChangedFcn =
createCallbackFcn(app, @SpecifyDataTypeDropDownValueChanged, true);
app.SpecifyDataTypeDropDown.Position = [154 256 53 22];
app.SpecifyDataTypeDropDown.Value = 'CONV Control';
% Create AnalyzePercentMelaninButton
app.AnalyzePercentMelaninButton =
uibutton(app.ImageEvaluationTab, 'push');
app.AnalyzePercentMelaninButton.ButtonPushedFcn =
createCallbackFcn(app, @AnalyzePercentMelaninButtonPushed, true);
app.AnalyzePercentMelaninButton.Position = [37 223 170
22];
app.AnalyzePercentMelaninButton.Text = ' Analyze Percent
Melanin';
% Create UITable
app.UITable = uitable(app.ImageEvaluationTab);
app.UITable.ColumnName = {'Date'; 'Data_Type';
'Percent_Melanin'; 'Total_Pixels'; 'White_Pixels'; 'Black_Pixels'};
app.UITable.RowName = {''; ''};
app.UITable.Position = [246 33 498 510];
% Create UIAxes
app.UIAxes = uiaxes(app.ImageEvaluationTab);
title(app.UIAxes, 'Selected Image')
xlabel(app.UIAxes, '')
ylabel(app.UIAxes, '')
app.UIAxes.PlotBoxAspectRatio = [1 0.854291417165669
0.854291417165669];
app.UIAxes.Position = [23 379 197 164];
% Create SelectxlsxButton
app.SelectxlsxButton = uibutton(app.ImageEvaluationTab,
'push');
app.SelectxlsxButton.ButtonPushedFcn =
createCallbackFcn(app, @SelectxlsxButtonPushed, true);
app.SelectxlsxButton.Position = [37 358 170 22];
app.SelectxlsxButton.Text = 'Select.xlsx';
% Create TextArea_2
app.TextArea_2 = uitextarea(app.ImageEvaluationTab);
app.TextArea_2.Position = [13 33 217 176];
app.TextArea_2.Value = {'Instructions:'; '1 ) Select new
.xlsx file pre-set with columns names in cells 1a-r'; '2) Upload
given image for analysis'; '3 ) Specify Date'; '4) Indicate Testing
Group'; '5) Press Analyze Button'; '6) Draw around epidermis sans
keratin'; '8) Data will automatically be uploaded to excel file'};
end
end
methods (Access = public)
% Construct app
function app = MelaninPigApp
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% Create and configure components
createComponents(app)
% Register the app with App Designer
registerApp(app, app.UIFigure)
if nargout == 0
clear app
end
end
% Code that executes before app deletion
function delete(app)
% Delete UIFigure when app is deleted
delete(app.UIFigure)
end
end
end
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